 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004775	succinate-CoA ligase (ADP-forming) activity	1	7.686783e-4	1.000000e+0	1.000000e+0	1.300934e+3	7.686783e-4	1	7.686783e-4	1.000000e+0	1	1.662879e-4	6.132698e-1	6.132698e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SUCLA2
GO Molecular Function	GO:0004774	succinate-CoA ligase activity	2	1.117684e-3	1.000000e+0	1.000000e+0	8.947070e+2	1.117684e-3	1	1.117684e-3	1.000000e+0	2	2.217172e-4	8.176930e-1	4.088465e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	SUCLA2
GO Molecular Function	GO:0016405	CoA-ligase activity	3	1.516694e-3	1.000000e+0	1.000000e+0	6.593286e+2	1.516694e-3	1	1.516694e-3	1.000000e+0	3	4.434344e-4	1.000000e+0	5.451287e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	SUCLA2
GO Molecular Function	GO:0016878	acid-thiol ligase activity	4	2.291531e-3	1.000000e+0	1.000000e+0	4.363894e+2	2.291531e-3	1	2.291531e-3	1.000000e+0	4	1.108586e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	SUCLA2
GO Molecular Function	GO:0016877	ligase activity, forming carbon-sulfur bonds	5	2.933778e-3	1.000000e+0	1.000000e+0	3.408575e+2	2.933778e-3	1	2.933778e-3	1.000000e+0	5	1.607450e-3	1.000000e+0	1.000000e+0	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	SUCLA2
GO Molecular Function	GO:0016874	ligase activity	6	4.606981e-2	1.000000e+0	1.000000e+0	2.170619e+1	4.606981e-2	1	4.606981e-2	1.000000e+0	6	2.754836e-2	1.000000e+0	1.000000e+0	3.629980e+1	2.754836e-2	1	497	1.000000e+0	2.012072e-3	unnamed	SUCLA2
GO Molecular Function	GO:0005524	ATP binding	7	1.376192e-1	1.000000e+0	1.000000e+0	7.266427e+0	1.376192e-1	1	1.376192e-1	1.000000e+0	7	8.148107e-2	1.000000e+0	1.000000e+0	1.227279e+1	8.148107e-2	1	1470	1.000000e+0	6.802721e-4	unnamed	SUCLA2
GO Molecular Function	GO:0032559	adenyl ribonucleotide binding	8	1.426806e-1	1.000000e+0	1.000000e+0	7.008664e+0	1.426806e-1	1	1.426806e-1	1.000000e+0	8	8.325481e-2	1.000000e+0	1.000000e+0	1.201132e+1	8.325481e-2	1	1502	1.000000e+0	6.657790e-4	unnamed	SUCLA2
GO Molecular Function	GO:0030554	adenyl nucleotide binding	9	1.431520e-1	1.000000e+0	1.000000e+0	6.985581e+0	1.431520e-1	1	1.431520e-1	1.000000e+0	9	8.408625e-2	1.000000e+0	1.000000e+0	1.189255e+1	8.408625e-2	1	1517	1.000000e+0	6.591958e-4	unnamed	SUCLA2
GO Molecular Function	GO:0035639	purine ribonucleoside triphosphate binding	10	1.642264e-1	1.000000e+0	1.000000e+0	6.089156e+0	1.642264e-1	1	1.642264e-1	1.000000e+0	10	1.001607e-1	1.000000e+0	1.000000e+0	9.983951e+0	1.001607e-1	1	1807	1.000000e+0	5.534034e-4	unnamed	SUCLA2
GO Molecular Function	GO:0032550	purine ribonucleoside binding	11	1.650919e-1	1.000000e+0	1.000000e+0	6.057234e+0	1.650919e-1	1	1.650919e-1	1.000000e+0	11	1.006596e-1	1.000000e+0	1.000000e+0	9.934471e+0	1.006596e-1	1	1816	1.000000e+0	5.506608e-4	unnamed	SUCLA2
GO Molecular Function	GO:0001883	purine nucleoside binding	12	1.651911e-1	1.000000e+0	1.000000e+0	6.053594e+0	1.651911e-1	1	1.651911e-1	1.000000e+0	12	1.008259e-1	1.000000e+0	1.000000e+0	9.918087e+0	1.008259e-1	1	1819	1.000000e+0	5.497526e-4	unnamed	SUCLA2
GO Molecular Function	GO:0032549	ribonucleoside binding	13	1.652867e-1	1.000000e+0	1.000000e+0	6.050092e+0	1.652867e-1	1	1.652867e-1	1.000000e+0	13	1.008813e-1	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	1820	1.000000e+0	5.494505e-4	unnamed	SUCLA2
GO Molecular Function	GO:0001882	nucleoside binding	14	1.658155e-1	1.000000e+0	1.000000e+0	6.030800e+0	1.658155e-1	1	1.658155e-1	1.000000e+0	14	1.014356e-1	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	1830	1.000000e+0	5.464481e-4	unnamed	SUCLA2
GO Molecular Function	GO:0032555	purine ribonucleotide binding	15	1.693981e-1	1.000000e+0	1.000000e+0	5.903255e+0	1.693981e-1	1	1.693981e-1	1.000000e+0	15	1.022671e-1	1.000000e+0	1.000000e+0	9.778320e+0	1.022671e-1	1	1845	1.000000e+0	5.420054e-4	unnamed	SUCLA2
GO Molecular Function	GO:0017076	purine nucleotide binding	16	1.701196e-1	1.000000e+0	1.000000e+0	5.878217e+0	1.701196e-1	1	1.701196e-1	1.000000e+0	17	1.032094e-1	1.000000e+0	1.000000e+0	9.689044e+0	1.032094e-1	1	1862	1.000000e+0	5.370569e-4	unnamed	SUCLA2
GO Molecular Function	GO:0032553	ribonucleotide binding	17	1.708664e-1	1.000000e+0	1.000000e+0	5.852525e+0	1.708664e-1	1	1.708664e-1	1.000000e+0	16	1.030431e-1	1.000000e+0	1.000000e+0	9.704680e+0	1.030431e-1	1	1859	1.000000e+0	5.379236e-4	unnamed	SUCLA2
GO Molecular Function	GO:0097367	carbohydrate derivative binding	18	1.996235e-1	1.000000e+0	1.000000e+0	5.009431e+0	1.996235e-1	1	1.996235e-1	1.000000e+0	18	1.185633e-1	1.000000e+0	1.000000e+0	8.434315e+0	1.185633e-1	1	2139	1.000000e+0	4.675082e-4	unnamed	SUCLA2
GO Molecular Function	GO:0000166	nucleotide binding	19	2.080686e-1	1.000000e+0	1.000000e+0	4.806107e+0	2.080686e-1	1	2.080686e-1	1.000000e+0	19	1.283188e-1	1.000000e+0	1.000000e+0	7.793089e+0	1.283188e-1	1	2315	1.000000e+0	4.319654e-4	unnamed	SUCLA2
GO Molecular Function	GO:1901265	nucleoside phosphate binding	20	2.081652e-1	1.000000e+0	1.000000e+0	4.803877e+0	2.081652e-1	1	2.081652e-1	1.000000e+0	20	1.283743e-1	1.000000e+0	1.000000e+0	7.789724e+0	1.283743e-1	1	2316	1.000000e+0	4.317789e-4	unnamed	SUCLA2
GO Molecular Function	GO:0036094	small molecule binding	21	2.286651e-1	1.000000e+0	1.000000e+0	4.373209e+0	2.286651e-1	1	2.286651e-1	1.000000e+0	21	1.422870e-1	1.000000e+0	1.000000e+0	7.028048e+0	1.422870e-1	1	2567	1.000000e+0	3.895598e-4	unnamed	SUCLA2
GO Molecular Function	GO:0043168	anion binding	22	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	22	1.510448e-1	1.000000e+0	1.000000e+0	6.620550e+0	1.510448e-1	1	2725	1.000000e+0	3.669725e-4	unnamed	SUCLA2
GO Molecular Function	GO:0046872	metal ion binding	23	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	23	2.197217e-1	1.000000e+0	1.000000e+0	4.551211e+0	2.197217e-1	1	3964	1.000000e+0	2.522704e-4	unnamed	SUCLA2
GO Molecular Function	GO:0043169	cation binding	24	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	24	2.233801e-1	1.000000e+0	1.000000e+0	4.476675e+0	2.233801e-1	1	4030	1.000000e+0	2.481390e-4	unnamed	SUCLA2
GO Molecular Function	GO:1901363	heterocyclic compound binding	25	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	25	2.937753e-1	1.000000e+0	1.000000e+0	3.403962e+0	2.937753e-1	1	5300	1.000000e+0	1.886792e-4	unnamed	SUCLA2
GO Molecular Function	GO:0097159	organic cyclic compound binding	26	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	26	2.978216e-1	1.000000e+0	1.000000e+0	3.357714e+0	2.978216e-1	1	5373	1.000000e+0	1.861158e-4	unnamed	SUCLA2
GO Molecular Function	GO:0003824	catalytic activity	27	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	27	3.045286e-1	1.000000e+0	1.000000e+0	3.283764e+0	3.045286e-1	1	5494	1.000000e+0	1.820167e-4	unnamed	SUCLA2
GO Molecular Function	GO:0043167	ion binding	28	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	28	3.344604e-1	1.000000e+0	1.000000e+0	2.989891e+0	3.344604e-1	1	6034	1.000000e+0	1.657275e-4	unnamed	SUCLA2
GO Molecular Function	GO:0005515	protein binding	29	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	29	4.432681e-1	1.000000e+0	1.000000e+0	2.255971e+0	4.432681e-1	1	7997	1.000000e+0	1.250469e-4	unnamed	SUCLA2
GO Molecular Function	GO:0005488	binding	30	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	30	6.747963e-1	1.000000e+0	1.000000e+0	1.481929e+0	6.747963e-1	1	12174	1.000000e+0	8.214227e-5	unnamed	SUCLA2
GO Biological Process	GO:0006781	succinyl-CoA pathway	1	3.604034e-4	1.000000e+0	1.000000e+0	2.774669e+3	3.604034e-4	1	3.604034e-4	1.000000e+0	1	5.542930e-5	5.786819e-1	5.786819e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	SUCLA2
GO Biological Process	GO:0006780	uroporphyrinogen III biosynthetic process	2	3.769711e-4	1.000000e+0	1.000000e+0	2.652723e+3	3.769711e-4	1	3.769711e-4	1.000000e+0	2	1.108586e-4	1.000000e+0	5.786819e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	SUCLA2
GO Biological Process	GO:0006104	succinyl-CoA metabolic process	3	1.146417e-3	1.000000e+0	1.000000e+0	8.722833e+2	1.146417e-3	1	1.146417e-3	1.000000e+0	3	2.771465e-4	1.000000e+0	9.644698e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	SUCLA2
GO Biological Process	GO:0006105	succinate metabolic process	4	1.483124e-3	1.000000e+0	1.000000e+0	6.742522e+2	1.483124e-3	1	1.483124e-3	1.000000e+0	4	5.542930e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	SUCLA2
GO Biological Process	GO:0006779	porphyrin-containing compound biosynthetic process	5	1.549716e-3	1.000000e+0	1.000000e+0	6.452796e+2	1.549716e-3	1	1.549716e-3	1.000000e+0	5	1.607450e-3	1.000000e+0	1.000000e+0	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	SUCLA2
GO Biological Process	GO:0033014	tetrapyrrole biosynthetic process	6	1.801542e-3	1.000000e+0	1.000000e+0	5.550800e+2	1.801542e-3	1	1.801542e-3	1.000000e+0	7	1.773738e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	32	1.000000e+0	3.125000e-2	unnamed	SUCLA2
GO Biological Process	GO:0006778	porphyrin-containing compound metabolic process	7	1.916607e-3	1.000000e+0	1.000000e+0	5.217553e+2	1.916607e-3	1	1.916607e-3	1.000000e+0	8	2.217172e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	SUCLA2
GO Biological Process	GO:0006099	tricarboxylic acid cycle	8	3.377873e-3	1.000000e+0	1.000000e+0	2.960443e+2	3.377873e-3	1	3.377873e-3	1.000000e+0	5	1.607450e-3	1.000000e+0	1.000000e+0	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	SUCLA2
GO Biological Process	GO:0009060	aerobic respiration	9	4.456193e-3	1.000000e+0	1.000000e+0	2.244068e+2	4.456193e-3	1	4.456193e-3	1.000000e+0	9	2.660606e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	48	1.000000e+0	2.083333e-2	unnamed	SUCLA2
GO Biological Process	GO:0033013	tetrapyrrole metabolic process	10	4.575450e-3	1.000000e+0	1.000000e+0	2.185577e+2	4.575450e-3	1	4.575450e-3	1.000000e+0	11	3.381187e-3	1.000000e+0	1.000000e+0	2.957541e+2	3.381187e-3	1	61	1.000000e+0	1.639344e-2	unnamed	SUCLA2
GO Biological Process	GO:0006637	acyl-CoA metabolic process	11	6.321660e-3	1.000000e+0	1.000000e+0	1.581863e+2	6.321660e-3	1	6.321660e-3	1.000000e+0	10	3.270329e-3	1.000000e+0	1.000000e+0	3.057797e+2	3.270329e-3	1	59	1.000000e+0	1.694915e-2	unnamed	SUCLA2
GO Biological Process	GO:0043648	dicarboxylic acid metabolic process	12	7.240154e-3	1.000000e+0	1.000000e+0	1.381186e+2	7.240154e-3	1	7.240154e-3	1.000000e+0	12	4.545203e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	82	1.000000e+0	1.219512e-2	unnamed	SUCLA2
GO Biological Process	GO:0045333	cellular respiration	13	1.138665e-2	1.000000e+0	1.000000e+0	8.782211e+1	1.138665e-2	1	1.138665e-2	1.000000e+0	14	8.757829e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	158	1.000000e+0	6.329114e-3	unnamed	SUCLA2
GO Biological Process	GO:0051188	cofactor biosynthetic process	14	1.142841e-2	1.000000e+0	1.000000e+0	8.750126e+1	1.142841e-2	1	1.142841e-2	1.000000e+0	13	7.316668e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	132	1.000000e+0	7.575758e-3	unnamed	SUCLA2
GO Biological Process	GO:0006732	coenzyme metabolic process	15	1.753259e-2	1.000000e+0	1.000000e+0	5.703664e+1	1.753259e-2	1	1.753259e-2	1.000000e+0	15	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	SUCLA2
GO Biological Process	GO:0051186	cofactor metabolic process	16	2.040573e-2	1.000000e+0	1.000000e+0	4.900585e+1	2.040573e-2	1	2.040573e-2	1.000000e+0	16	1.358018e-2	1.000000e+0	1.000000e+0	7.363673e+1	1.358018e-2	1	245	1.000000e+0	4.081633e-3	unnamed	SUCLA2
GO Biological Process	GO:0046394	carboxylic acid biosynthetic process	17	2.519210e-2	1.000000e+0	1.000000e+0	3.969498e+1	2.519210e-2	1	2.519210e-2	1.000000e+0	17	1.513220e-2	1.000000e+0	1.000000e+0	6.608425e+1	1.513220e-2	1	273	1.000000e+0	3.663004e-3	unnamed	SUCLA2
GO Biological Process	GO:0015980	energy derivation by oxidation of organic compounds	18	2.768651e-2	1.000000e+0	1.000000e+0	3.611867e+1	2.768651e-2	1	2.768651e-2	1.000000e+0	18	1.690594e-2	1.000000e+0	1.000000e+0	5.915082e+1	1.690594e-2	1	305	1.000000e+0	3.278689e-3	unnamed	SUCLA2
GO Biological Process	GO:0006091	generation of precursor metabolites and energy	19	3.205061e-2	1.000000e+0	1.000000e+0	3.120066e+1	3.205061e-2	1	3.205061e-2	1.000000e+0	19	2.100770e-2	1.000000e+0	1.000000e+0	4.760158e+1	2.100770e-2	1	379	1.000000e+0	2.638522e-3	unnamed	SUCLA2
GO Biological Process	GO:0044283	small molecule biosynthetic process	20	3.466661e-2	1.000000e+0	1.000000e+0	2.884620e+1	3.466661e-2	1	3.466661e-2	1.000000e+0	20	2.178371e-2	1.000000e+0	1.000000e+0	4.590585e+1	2.178371e-2	1	393	1.000000e+0	2.544529e-3	unnamed	SUCLA2
GO Biological Process	GO:0044711	single-organism biosynthetic process	21	3.645402e-2	1.000000e+0	1.000000e+0	2.743181e+1	3.645402e-2	1	3.645402e-2	1.000000e+0	21	2.244887e-2	1.000000e+0	1.000000e+0	4.454568e+1	2.244887e-2	1	405	1.000000e+0	2.469136e-3	unnamed	SUCLA2
GO Biological Process	GO:1901566	organonitrogen compound biosynthetic process	22	5.924039e-2	1.000000e+0	1.000000e+0	1.688038e+1	5.924039e-2	1	5.924039e-2	1.000000e+0	22	3.104041e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	560	1.000000e+0	1.785714e-3	unnamed	SUCLA2
GO Biological Process	GO:0019752	carboxylic acid metabolic process	23	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	23	4.467602e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	806	1.000000e+0	1.240695e-3	unnamed	SUCLA2
GO Biological Process	GO:0055114	oxidation-reduction process	24	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	25	5.116124e-2	1.000000e+0	1.000000e+0	1.954605e+1	5.116124e-2	1	923	1.000000e+0	1.083424e-3	unnamed	SUCLA2
GO Biological Process	GO:0043436	oxoacid metabolic process	25	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	24	5.088410e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	918	1.000000e+0	1.089325e-3	unnamed	SUCLA2
GO Biological Process	GO:0006082	organic acid metabolic process	26	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	26	5.177097e-2	1.000000e+0	1.000000e+0	1.931585e+1	5.177097e-2	1	934	1.000000e+0	1.070664e-3	unnamed	SUCLA2
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	27	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	27	8.552741e-2	1.000000e+0	1.000000e+0	1.169216e+1	8.552741e-2	1	1543	1.000000e+0	6.480881e-4	unnamed	SUCLA2
GO Biological Process	GO:0006793	phosphorus metabolic process	28	1.905359e-1	1.000000e+0	1.000000e+0	5.248354e+0	1.905359e-1	1	1.905359e-1	1.000000e+0	28	1.145169e-1	1.000000e+0	1.000000e+0	8.732333e+0	1.145169e-1	1	2066	1.000000e+0	4.840271e-4	unnamed	SUCLA2
GO Biological Process	GO:0044281	small molecule metabolic process	29	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	29	1.345269e-1	1.000000e+0	1.000000e+0	7.433457e+0	1.345269e-1	1	2427	1.000000e+0	4.120313e-4	unnamed	SUCLA2
GO Biological Process	GO:0018130	heterocycle biosynthetic process	30	2.497654e-1	1.000000e+0	1.000000e+0	4.003758e+0	2.497654e-1	1	2.497654e-1	1.000000e+0	30	1.555346e-1	1.000000e+0	1.000000e+0	6.429437e+0	1.555346e-1	1	2806	1.000000e+0	3.563792e-4	unnamed	SUCLA2
GO Biological Process	GO:0019438	aromatic compound biosynthetic process	31	2.512206e-1	1.000000e+0	1.000000e+0	3.980565e+0	2.512206e-1	1	2.512206e-1	1.000000e+0	31	1.555900e-1	1.000000e+0	1.000000e+0	6.427146e+0	1.555900e-1	1	2807	1.000000e+0	3.562522e-4	unnamed	SUCLA2
GO Biological Process	GO:0044710	single-organism metabolic process	32	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	34	1.696691e-1	1.000000e+0	1.000000e+0	5.893826e+0	1.696691e-1	1	3061	1.000000e+0	3.266906e-4	unnamed	SUCLA2
GO Biological Process	GO:0044271	cellular nitrogen compound biosynthetic process	33	2.531794e-1	1.000000e+0	1.000000e+0	3.949768e+0	2.531794e-1	1	2.531794e-1	1.000000e+0	32	1.584169e-1	1.000000e+0	1.000000e+0	6.312456e+0	1.584169e-1	1	2858	1.000000e+0	3.498950e-4	unnamed	SUCLA2
GO Biological Process	GO:1901362	organic cyclic compound biosynthetic process	34	2.593182e-1	1.000000e+0	1.000000e+0	3.856266e+0	2.593182e-1	1	2.593182e-1	1.000000e+0	33	1.620753e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	2924	1.000000e+0	3.419973e-4	unnamed	SUCLA2
GO Biological Process	GO:0044249	cellular biosynthetic process	35	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	35	2.280916e-1	1.000000e+0	1.000000e+0	4.384204e+0	2.280916e-1	1	4115	1.000000e+0	2.430134e-4	unnamed	SUCLA2
GO Biological Process	GO:1901576	organic substance biosynthetic process	36	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	36	2.330802e-1	1.000000e+0	1.000000e+0	4.290369e+0	2.330802e-1	1	4205	1.000000e+0	2.378121e-4	unnamed	SUCLA2
GO Biological Process	GO:0009058	biosynthetic process	37	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	37	2.370157e-1	1.000000e+0	1.000000e+0	4.219130e+0	2.370157e-1	1	4276	1.000000e+0	2.338634e-4	unnamed	SUCLA2
GO Biological Process	GO:0046483	heterocycle metabolic process	38	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	38	2.580788e-1	1.000000e+0	1.000000e+0	3.874785e+0	2.580788e-1	1	4656	1.000000e+0	2.147766e-4	unnamed	SUCLA2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	39	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	39	2.587994e-1	1.000000e+0	1.000000e+0	3.863997e+0	2.587994e-1	1	4669	1.000000e+0	2.141786e-4	unnamed	SUCLA2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	40	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	40	2.694973e-1	1.000000e+0	1.000000e+0	3.710613e+0	2.694973e-1	1	4862	1.000000e+0	2.056767e-4	unnamed	SUCLA2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	41	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	41	2.708830e-1	1.000000e+0	1.000000e+0	3.691631e+0	2.708830e-1	1	4887	1.000000e+0	2.046245e-4	unnamed	SUCLA2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	42	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	42	2.925004e-1	1.000000e+0	1.000000e+0	3.418799e+0	2.925004e-1	1	5277	1.000000e+0	1.895016e-4	unnamed	SUCLA2
GO Biological Process	GO:0044237	cellular metabolic process	43	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	43	4.564049e-1	1.000000e+0	1.000000e+0	2.191037e+0	4.564049e-1	1	8234	1.000000e+0	1.214477e-4	unnamed	SUCLA2
GO Biological Process	GO:0044238	primary metabolic process	44	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	44	4.608946e-1	1.000000e+0	1.000000e+0	2.169693e+0	4.608946e-1	1	8315	1.000000e+0	1.202646e-4	unnamed	SUCLA2
GO Biological Process	GO:0071704	organic substance metabolic process	45	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	45	4.745857e-1	1.000000e+0	1.000000e+0	2.107101e+0	4.745857e-1	1	8562	1.000000e+0	1.167951e-4	unnamed	SUCLA2
GO Biological Process	GO:0008152	metabolic process	46	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	46	5.097278e-1	1.000000e+0	1.000000e+0	1.961831e+0	5.097278e-1	1	9196	1.000000e+0	1.087429e-4	unnamed	SUCLA2
GO Biological Process	GO:0009987	cellular process	47	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	47	7.487944e-1	1.000000e+0	1.000000e+0	1.335480e+0	7.487944e-1	1	13509	1.000000e+0	7.402472e-5	unnamed	SUCLA2
GO Cellular Component	GO:0005759	mitochondrial matrix	1	2.150026e-2	1.000000e+0	1.000000e+0	4.651106e+1	2.150026e-2	1	2.150026e-2	1.000000e+0	1	1.701680e-2	1.000000e+0	1.000000e+0	5.876547e+1	1.701680e-2	1	307	1.000000e+0	3.257329e-3	unnamed	SUCLA2
GO Cellular Component	GO:0044429	mitochondrial part	2	5.499540e-2	1.000000e+0	1.000000e+0	1.818334e+1	5.499540e-2	1	5.499540e-2	1.000000e+0	2	4.395543e-2	1.000000e+0	1.000000e+0	2.275032e+1	4.395543e-2	1	793	1.000000e+0	1.261034e-3	unnamed	SUCLA2
GO Cellular Component	GO:0005739	mitochondrion	3	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	3	8.791087e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	1586	1.000000e+0	6.305170e-4	unnamed	SUCLA2
GO Cellular Component	GO:0070013	intracellular organelle lumen	4	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	4	1.491048e-1	1.000000e+0	1.000000e+0	6.706691e+0	1.491048e-1	1	2690	1.000000e+0	3.717472e-4	unnamed	SUCLA2
GO Cellular Component	GO:0043233	organelle lumen	5	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	5	1.524306e-1	1.000000e+0	1.000000e+0	6.560364e+0	1.524306e-1	1	2750	1.000000e+0	3.636364e-4	unnamed	SUCLA2
GO Cellular Component	GO:0031974	membrane-enclosed lumen	6	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	6	1.552020e-1	1.000000e+0	1.000000e+0	6.443214e+0	1.552020e-1	1	2800	1.000000e+0	3.571429e-4	unnamed	SUCLA2
GO Cellular Component	GO:0044446	intracellular organelle part	7	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	7	3.595144e-1	1.000000e+0	1.000000e+0	2.781529e+0	3.595144e-1	1	6486	1.000000e+0	1.541782e-4	unnamed	SUCLA2
GO Cellular Component	GO:0044422	organelle part	8	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	8	3.657225e-1	1.000000e+0	1.000000e+0	2.734313e+0	3.657225e-1	1	6598	1.000000e+0	1.515611e-4	unnamed	SUCLA2
GO Cellular Component	GO:0044444	cytoplasmic part	9	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	9	3.898343e-1	1.000000e+0	1.000000e+0	2.565193e+0	3.898343e-1	1	7033	1.000000e+0	1.421868e-4	unnamed	SUCLA2
GO Cellular Component	GO:0005737	cytoplasm	10	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	10	5.240840e-1	1.000000e+0	1.000000e+0	1.908091e+0	5.240840e-1	1	9455	1.000000e+0	1.057641e-4	unnamed	SUCLA2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	11	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	11	5.549582e-1	1.000000e+0	1.000000e+0	1.801938e+0	5.549582e-1	1	10012	1.000000e+0	9.988014e-5	unnamed	SUCLA2
GO Cellular Component	GO:0043227	membrane-bounded organelle	12	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	12	5.568427e-1	1.000000e+0	1.000000e+0	1.795839e+0	5.568427e-1	1	10046	1.000000e+0	9.954211e-5	unnamed	SUCLA2
GO Cellular Component	GO:0043229	intracellular organelle	13	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	13	6.092789e-1	1.000000e+0	1.000000e+0	1.641285e+0	6.092789e-1	1	10992	1.000000e+0	9.097525e-5	unnamed	SUCLA2
GO Cellular Component	GO:0043226	organelle	14	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	14	6.110526e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	11024	1.000000e+0	9.071118e-5	unnamed	SUCLA2
GO Cellular Component	GO:0044424	intracellular part	15	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	15	6.971897e-1	1.000000e+0	1.000000e+0	1.434330e+0	6.971897e-1	1	12578	1.000000e+0	7.950390e-5	unnamed	SUCLA2
GO Cellular Component	GO:0005622	intracellular	16	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	16	7.066127e-1	1.000000e+0	1.000000e+0	1.415202e+0	7.066127e-1	1	12748	1.000000e+0	7.844368e-5	unnamed	SUCLA2
GO Cellular Component	GO:0044464	cell part	17	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	17	8.202982e-1	1.000000e+0	1.000000e+0	1.219069e+0	8.202982e-1	1	14799	1.000000e+0	6.757213e-5	unnamed	SUCLA2
GO Cellular Component	GO:0005623	cell	18	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	18	8.203536e-1	1.000000e+0	1.000000e+0	1.218986e+0	8.203536e-1	1	14800	1.000000e+0	6.756757e-5	unnamed	SUCLA2
Human Phenotype	HP:0008945	Loss of ability to walk in early childhood	1	4.048286e-4	1.000000e+0	1.000000e+0	2.470181e+3	4.048286e-4	1	4.048286e-4	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	SUCLA2
Human Phenotype	HP:0002448	Progressive encephalopathy	2	4.134343e-4	1.000000e+0	1.000000e+0	2.418764e+3	4.134343e-4	1	4.134343e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	5.110027e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SUCLA2
Human Phenotype	HP:0006915	Inability to walk by childhood/adolescence	3	5.771976e-4	1.000000e+0	1.000000e+0	1.732509e+3	5.771976e-4	1	5.771976e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	5.110027e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SUCLA2
Human Phenotype	HP:0008972	Decreased activity of mitochondrial respiratory chain	4	7.227234e-4	1.000000e+0	1.000000e+0	1.383655e+3	7.227234e-4	1	7.227234e-4	1.000000e+0	8	6.651516e-4	1.000000e+0	5.110027e-1	1.503417e+3	6.651516e-4	1	12	1.000000e+0	8.333333e-2	unnamed	SUCLA2
Human Phenotype	HP:0001349	Facial diplegia	5	7.648518e-4	1.000000e+0	9.401558e-1	1.307443e+3	7.648518e-4	1	7.648518e-4	1.000000e+0	6	5.542930e-4	1.000000e+0	5.677808e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	SUCLA2
Human Phenotype	HP:0002505	Progressive inability to walk	6	7.904222e-4	1.000000e+0	8.096558e-1	1.265147e+3	7.904222e-4	1	7.904222e-4	1.000000e+0	4	4.434344e-4	1.000000e+0	6.813370e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	SUCLA2
Human Phenotype	HP:0002305	Athetosis	7	1.720507e-3	1.000000e+0	1.000000e+0	5.812239e+2	1.720507e-3	1	1.720507e-3	1.000000e+0	9	7.205809e-4	1.000000e+0	4.920767e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	SUCLA2
Human Phenotype	HP:0002540	Inability to walk	8	1.765043e-3	1.000000e+0	1.000000e+0	5.665586e+2	1.765043e-3	1	1.765043e-3	1.000000e+0	7	6.097223e-4	1.000000e+0	5.353362e-1	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	SUCLA2
Human Phenotype	HP:0002912	Methylmalonic acidemia	9	1.798198e-3	1.000000e+0	1.000000e+0	5.561124e+2	1.798198e-3	1	1.798198e-3	1.000000e+0	5	4.988637e-4	1.000000e+0	6.132033e-1	2.004556e+3	4.988637e-4	1	9	1.000000e+0	1.111111e-1	unnamed	SUCLA2
Human Phenotype	HP:0002194	Delayed gross motor development	10	2.077877e-3	1.000000e+0	1.000000e+0	4.812603e+2	2.077877e-3	1	2.077877e-3	1.000000e+0	13	1.053157e-3	1.000000e+0	4.979002e-1	9.495263e+2	1.053157e-3	1	19	1.000000e+0	5.263158e-2	unnamed	SUCLA2
Human Phenotype	HP:0012120	Methylmalonic aciduria	11	2.279227e-3	1.000000e+0	1.000000e+0	4.387452e+2	2.279227e-3	1	2.279227e-3	1.000000e+0	9	7.205809e-4	1.000000e+0	4.920767e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	SUCLA2
Human Phenotype	HP:0004341	Abnormality of the vitamin B12 metabolism	12	2.575064e-3	1.000000e+0	1.000000e+0	3.883399e+2	2.575064e-3	1	2.575064e-3	1.000000e+0	11	8.314395e-4	1.000000e+0	4.645479e-1	1.202733e+3	8.314395e-4	1	15	1.000000e+0	6.666667e-2	unnamed	SUCLA2
Human Phenotype	HP:0004340	Abnormality of vitamin B metabolism	13	2.639607e-3	1.000000e+0	1.000000e+0	3.788442e+2	2.639607e-3	1	2.639607e-3	1.000000e+0	12	8.868688e-4	1.000000e+0	4.542246e-1	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	SUCLA2
Human Phenotype	HP:0000649	Abnormality of vision evoked potentials	14	2.696074e-3	1.000000e+0	1.000000e+0	3.709097e+2	2.696074e-3	1	2.696074e-3	1.000000e+0	15	1.441162e-3	1.000000e+0	5.904921e-1	6.938846e+2	1.441162e-3	1	26	1.000000e+0	3.846154e-2	unnamed	SUCLA2
Human Phenotype	HP:0100508	Abnormality of vitamin metabolism	15	2.947287e-3	1.000000e+0	1.000000e+0	3.392951e+2	2.947287e-3	1	2.947287e-3	1.000000e+0	14	1.108586e-3	1.000000e+0	4.866693e-1	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	SUCLA2
Human Phenotype	HP:0002747	Respiratory insufficiency due to muscle weakness	16	3.300881e-3	1.000000e+0	1.000000e+0	3.029494e+2	3.300881e-3	1	3.300881e-3	1.000000e+0	19	2.217172e-3	1.000000e+0	7.171968e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	SUCLA2
Human Phenotype	HP:0003215	Dicarboxylic aciduria	17	3.313993e-3	1.000000e+0	1.000000e+0	3.017508e+2	3.313993e-3	1	3.313993e-3	1.000000e+0	16	1.662879e-3	1.000000e+0	6.387534e-1	6.013667e+2	1.662879e-3	1	30	1.000000e+0	3.333333e-2	unnamed	SUCLA2
Human Phenotype	HP:0004347	Weakness of muscles of respiration	18	3.387907e-3	1.000000e+0	1.000000e+0	2.951675e+2	3.387907e-3	1	3.387907e-3	1.000000e+0	20	2.383460e-3	1.000000e+0	7.324373e-1	4.195581e+2	2.383460e-3	1	43	1.000000e+0	2.325581e-2	unnamed	SUCLA2
Human Phenotype	HP:0000737	Irritability	19	3.772982e-3	1.000000e+0	1.000000e+0	2.650424e+2	3.772982e-3	1	3.772982e-3	1.000000e+0	21	2.549748e-3	1.000000e+0	7.462262e-1	3.921957e+2	2.549748e-3	1	46	1.000000e+0	2.173913e-2	unnamed	SUCLA2
Human Phenotype	HP:0002134	Abnormality of the basal ganglia	20	3.810741e-3	1.000000e+0	1.000000e+0	2.624161e+2	3.810741e-3	1	3.810741e-3	1.000000e+0	17	1.884596e-3	1.000000e+0	6.813369e-1	5.306176e+2	1.884596e-3	1	34	1.000000e+0	2.941176e-2	unnamed	SUCLA2
Human Phenotype	HP:0003287	Abnormality of mitochondrial metabolism	21	3.967787e-3	1.000000e+0	1.000000e+0	2.520296e+2	3.967787e-3	1	3.967787e-3	1.000000e+0	23	3.048611e-3	1.000000e+0	8.146419e-1	3.280182e+2	3.048611e-3	1	55	1.000000e+0	1.818182e-2	unnamed	SUCLA2
Human Phenotype	HP:0012103	Abnormality of the mitochondrion	22	4.073392e-3	1.000000e+0	1.000000e+0	2.454956e+2	4.073392e-3	1	4.073392e-3	1.000000e+0	24	3.214899e-3	1.000000e+0	8.232821e-1	3.110517e+2	3.214899e-3	1	58	1.000000e+0	1.724138e-2	unnamed	SUCLA2
Human Phenotype	HP:0000602	Ophthalmoplegia	23	4.301437e-3	1.000000e+0	1.000000e+0	2.324805e+2	4.301437e-3	1	4.301437e-3	1.000000e+0	22	2.937753e-3	1.000000e+0	8.207014e-1	3.403962e+2	2.937753e-3	1	53	1.000000e+0	1.886792e-2	unnamed	SUCLA2
Human Phenotype	HP:0006887	Intellectual disability, progressive	24	4.762519e-3	1.000000e+0	1.000000e+0	2.099729e+2	4.762519e-3	1	4.762519e-3	1.000000e+0	18	2.050884e-3	1.000000e+0	7.002629e-1	4.875946e+2	2.050884e-3	1	37	1.000000e+0	2.702703e-2	unnamed	SUCLA2
Human Phenotype	HP:0002514	Cerebral calcification	25	5.503631e-3	1.000000e+0	1.000000e+0	1.816982e+2	5.503631e-3	1	5.503631e-3	1.000000e+0	26	3.658334e-3	1.000000e+0	8.647739e-1	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	SUCLA2
Human Phenotype	HP:0000762	Decreased nerve conduction velocity	26	6.308917e-3	1.000000e+0	1.000000e+0	1.585058e+2	6.308917e-3	1	6.308917e-3	1.000000e+0	25	3.547475e-3	1.000000e+0	8.721113e-1	2.818906e+2	3.547475e-3	1	64	1.000000e+0	1.562500e-2	unnamed	SUCLA2
Human Phenotype	HP:0001298	Encephalopathy	27	6.546159e-3	1.000000e+0	1.000000e+0	1.527613e+2	6.546159e-3	1	6.546159e-3	1.000000e+0	28	3.824622e-3	1.000000e+0	8.395045e-1	2.614638e+2	3.824622e-3	1	69	1.000000e+0	1.449275e-2	unnamed	SUCLA2
Human Phenotype	HP:0003134	Abnormality of peripheral nerve conduction	28	6.625753e-3	1.000000e+0	1.000000e+0	1.509262e+2	6.625753e-3	1	6.625753e-3	1.000000e+0	26	3.658334e-3	1.000000e+0	8.647739e-1	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	SUCLA2
Human Phenotype	HP:0003128	Lactic acidosis	29	7.763196e-3	1.000000e+0	1.000000e+0	1.288129e+2	7.763196e-3	1	7.763196e-3	1.000000e+0	31	5.598359e-3	1.000000e+0	1.000000e+0	1.786238e+2	5.598359e-3	1	101	1.000000e+0	9.900990e-3	unnamed	SUCLA2
Human Phenotype	HP:0003355	Aminoaciduria	30	8.458357e-3	1.000000e+0	1.000000e+0	1.182263e+2	8.458357e-3	1	8.458357e-3	1.000000e+0	29	4.822349e-3	1.000000e+0	1.000000e+0	2.073678e+2	4.822349e-3	1	87	1.000000e+0	1.149425e-2	unnamed	SUCLA2
Human Phenotype	HP:0010628	Facial palsy	31	8.545097e-3	1.000000e+0	1.000000e+0	1.170262e+2	8.545097e-3	1	8.545097e-3	1.000000e+0	30	5.265783e-3	1.000000e+0	1.000000e+0	1.899053e+2	5.265783e-3	1	95	1.000000e+0	1.052632e-2	unnamed	SUCLA2
Human Phenotype	HP:0000301	Abnormality of facial musculature	32	9.970681e-3	1.000000e+0	1.000000e+0	1.002941e+2	9.970681e-3	1	9.970681e-3	1.000000e+0	32	5.875506e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	106	1.000000e+0	9.433962e-3	unnamed	SUCLA2
Human Phenotype	HP:0012072	Aciduria	33	1.017783e-2	1.000000e+0	1.000000e+0	9.825273e+1	1.017783e-2	1	1.017783e-2	1.000000e+0	34	6.152652e-3	1.000000e+0	1.000000e+0	1.625315e+2	6.152652e-3	1	111	1.000000e+0	9.009009e-3	unnamed	SUCLA2
Human Phenotype	HP:0001332	Dystonia	34	1.072440e-2	1.000000e+0	1.000000e+0	9.324529e+1	1.072440e-2	1	1.072440e-2	1.000000e+0	37	6.984092e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	126	1.000000e+0	7.936508e-3	unnamed	SUCLA2
Human Phenotype	HP:0003236	Elevated serum creatine phosphokinase	35	1.086509e-2	1.000000e+0	1.000000e+0	9.203792e+1	1.086509e-2	1	1.086509e-2	1.000000e+0	32	5.875506e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	106	1.000000e+0	9.433962e-3	unnamed	SUCLA2
Human Phenotype	HP:0000512	Abnormal electroretinogram	36	1.139741e-2	1.000000e+0	1.000000e+0	8.773922e+1	1.139741e-2	1	1.139741e-2	1.000000e+0	38	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	SUCLA2
Human Phenotype	HP:0010766	Ectopic calcification	37	1.167996e-2	1.000000e+0	1.000000e+0	8.561675e+1	1.167996e-2	1	1.167996e-2	1.000000e+0	39	7.150380e-3	1.000000e+0	1.000000e+0	1.398527e+2	7.150380e-3	1	129	1.000000e+0	7.751938e-3	unnamed	SUCLA2
Human Phenotype	HP:0011017	Abnormality of cell physiology	38	1.169780e-2	1.000000e+0	1.000000e+0	8.548614e+1	1.169780e-2	1	1.169780e-2	1.000000e+0	36	6.762375e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	122	1.000000e+0	8.196721e-3	unnamed	SUCLA2
Human Phenotype	HP:0000597	Ophthalmoparesis	39	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	45	8.369824e-3	1.000000e+0	1.000000e+0	1.194768e+2	8.369824e-3	1	151	1.000000e+0	6.622517e-3	unnamed	SUCLA2
Human Phenotype	HP:0004337	Abnormality of amino acid metabolism	40	1.235776e-2	1.000000e+0	1.000000e+0	8.092080e+1	1.235776e-2	1	1.235776e-2	1.000000e+0	35	6.485228e-3	1.000000e+0	1.000000e+0	1.541966e+2	6.485228e-3	1	117	1.000000e+0	8.547009e-3	unnamed	SUCLA2
Human Phenotype	HP:0006824	Cranial nerve paralysis	41	1.341073e-2	1.000000e+0	1.000000e+0	7.456717e+1	1.341073e-2	1	1.341073e-2	1.000000e+0	40	7.593814e-3	1.000000e+0	1.000000e+0	1.316861e+2	7.593814e-3	1	137	1.000000e+0	7.299270e-3	unnamed	SUCLA2
Human Phenotype	HP:0004354	Abnormality of carboxylic acid metabolism	42	1.349326e-2	1.000000e+0	1.000000e+0	7.411106e+1	1.349326e-2	1	1.349326e-2	1.000000e+0	42	7.704673e-3	1.000000e+0	1.000000e+0	1.297914e+2	7.704673e-3	1	139	1.000000e+0	7.194245e-3	unnamed	SUCLA2
Human Phenotype	HP:0001265	Hyporeflexia	43	1.363560e-2	1.000000e+0	1.000000e+0	7.333742e+1	1.363560e-2	1	1.363560e-2	1.000000e+0	44	7.760102e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	140	1.000000e+0	7.142857e-3	unnamed	SUCLA2
Human Phenotype	HP:0010876	Abnormality of circulating protein level	44	1.386661e-2	1.000000e+0	1.000000e+0	7.211570e+1	1.386661e-2	1	1.386661e-2	1.000000e+0	42	7.704673e-3	1.000000e+0	1.000000e+0	1.297914e+2	7.704673e-3	1	139	1.000000e+0	7.194245e-3	unnamed	SUCLA2
Human Phenotype	HP:0001291	Abnormality of the cranial nerves	45	1.478944e-2	1.000000e+0	1.000000e+0	6.761580e+1	1.478944e-2	1	1.478944e-2	1.000000e+0	46	8.425254e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	152	1.000000e+0	6.578947e-3	unnamed	SUCLA2
Human Phenotype	HP:0001941	Acidosis	46	1.550843e-2	1.000000e+0	1.000000e+0	6.448106e+1	1.550843e-2	1	1.550843e-2	1.000000e+0	51	1.069785e-2	1.000000e+0	1.000000e+0	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	SUCLA2
Human Phenotype	HP:0011799	Abnormality of facial soft tissue	47	1.583064e-2	1.000000e+0	1.000000e+0	6.316864e+1	1.583064e-2	1	1.583064e-2	1.000000e+0	47	8.979547e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	162	1.000000e+0	6.172840e-3	unnamed	SUCLA2
Human Phenotype	HP:0004305	Involuntary movements	48	1.586953e-2	1.000000e+0	1.000000e+0	6.301385e+1	1.586953e-2	1	1.586953e-2	1.000000e+0	49	9.533840e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	172	1.000000e+0	5.813953e-3	unnamed	SUCLA2
Human Phenotype	HP:0000998	Hypertrichosis	49	1.653657e-2	1.000000e+0	1.000000e+0	6.047204e+1	1.653657e-2	1	1.653657e-2	1.000000e+0	41	7.649243e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	138	1.000000e+0	7.246377e-3	unnamed	SUCLA2
Human Phenotype	HP:0004360	Abnormality of acid-base homeostasis	50	1.679508e-2	1.000000e+0	1.000000e+0	5.954125e+1	1.679508e-2	1	1.679508e-2	1.000000e+0	54	1.152929e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	208	1.000000e+0	4.807692e-3	unnamed	SUCLA2
Human Phenotype	HP:0001270	Motor delay	51	1.852296e-2	1.000000e+0	1.000000e+0	5.398706e+1	1.852296e-2	1	1.852296e-2	1.000000e+0	48	9.312122e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	168	1.000000e+0	5.952381e-3	unnamed	SUCLA2
Human Phenotype	HP:0001257	Spasticity	52	2.102269e-2	1.000000e+0	1.000000e+0	4.756765e+1	2.102269e-2	1	2.102269e-2	1.000000e+0	63	1.424533e-2	1.000000e+0	1.000000e+0	7.019844e+1	1.424533e-2	1	257	1.000000e+0	3.891051e-3	unnamed	SUCLA2
Human Phenotype	HP:0002059	Cerebral atrophy	53	2.274528e-2	1.000000e+0	1.000000e+0	4.396517e+1	2.274528e-2	1	2.274528e-2	1.000000e+0	52	1.114129e-2	1.000000e+0	1.000000e+0	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	SUCLA2
Human Phenotype	HP:0007369	Atrophy/Degeneration affecting the cerebrum	54	2.306765e-2	1.000000e+0	1.000000e+0	4.335075e+1	2.306765e-2	1	2.306765e-2	1.000000e+0	53	1.136301e-2	1.000000e+0	1.000000e+0	8.800488e+1	1.136301e-2	1	205	1.000000e+0	4.878049e-3	unnamed	SUCLA2
Human Phenotype	HP:0002119	Ventriculomegaly	55	2.314602e-2	1.000000e+0	1.000000e+0	4.320398e+1	2.314602e-2	1	2.314602e-2	1.000000e+0	50	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SUCLA2
Human Phenotype	HP:0003110	Abnormality of urine homeostasis	56	2.316703e-2	1.000000e+0	1.000000e+0	4.316480e+1	2.316703e-2	1	2.316703e-2	1.000000e+0	65	1.557563e-2	1.000000e+0	1.000000e+0	6.420285e+1	1.557563e-2	1	281	1.000000e+0	3.558719e-3	unnamed	SUCLA2
Human Phenotype	HP:0012444	Brain atrophy	57	2.343110e-2	1.000000e+0	1.000000e+0	4.267832e+1	2.343110e-2	1	2.343110e-2	1.000000e+0	55	1.164015e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	210	1.000000e+0	4.761905e-3	unnamed	SUCLA2
Human Phenotype	HP:0001315	Reduced tendon reflexes	58	2.367878e-2	1.000000e+0	1.000000e+0	4.223191e+1	2.367878e-2	1	2.367878e-2	1.000000e+0	57	1.297046e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	234	1.000000e+0	4.273504e-3	unnamed	SUCLA2
Human Phenotype	HP:0009830	Peripheral neuropathy	59	2.399642e-2	1.000000e+0	1.000000e+0	4.167288e+1	2.399642e-2	1	2.399642e-2	1.000000e+0	60	1.385732e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	250	1.000000e+0	4.000000e-3	unnamed	SUCLA2
Human Phenotype	HP:0008872	Feeding difficulties in infancy	60	2.531351e-2	1.000000e+0	1.000000e+0	3.950459e+1	2.531351e-2	1	2.531351e-2	1.000000e+0	58	1.319217e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	238	1.000000e+0	4.201681e-3	unnamed	SUCLA2
Human Phenotype	HP:0002311	Incoordination	61	2.557425e-2	1.000000e+0	1.000000e+0	3.910184e+1	2.557425e-2	1	2.557425e-2	1.000000e+0	56	1.208359e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	218	1.000000e+0	4.587156e-3	unnamed	SUCLA2
Human Phenotype	HP:0007367	Atrophy/Degeneration affecting the central nervous system	62	2.578991e-2	1.000000e+0	1.000000e+0	3.877485e+1	2.578991e-2	1	2.578991e-2	1.000000e+0	59	1.352475e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	244	1.000000e+0	4.098361e-3	unnamed	SUCLA2
Human Phenotype	HP:0003593	Infantile onset	63	2.620028e-2	1.000000e+0	1.000000e+0	3.816753e+1	2.620028e-2	1	2.620028e-2	1.000000e+0	62	1.413447e-2	1.000000e+0	1.000000e+0	7.074902e+1	1.413447e-2	1	255	1.000000e+0	3.921569e-3	unnamed	SUCLA2
Human Phenotype	HP:0003202	Amyotrophy	64	2.705294e-2	1.000000e+0	1.000000e+0	3.696455e+1	2.705294e-2	1	2.705294e-2	1.000000e+0	67	1.596364e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	288	1.000000e+0	3.472222e-3	unnamed	SUCLA2
Human Phenotype	HP:0002093	Respiratory insufficiency	65	2.790110e-2	1.000000e+0	1.000000e+0	3.584089e+1	2.790110e-2	1	2.790110e-2	1.000000e+0	71	1.734937e-2	1.000000e+0	1.000000e+0	5.763898e+1	1.734937e-2	1	313	1.000000e+0	3.194888e-3	unnamed	SUCLA2
Human Phenotype	HP:0001508	Failure to thrive	66	2.902184e-2	1.000000e+0	1.000000e+0	3.445681e+1	2.902184e-2	1	2.902184e-2	1.000000e+0	69	1.685051e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	304	1.000000e+0	3.289474e-3	unnamed	SUCLA2
Human Phenotype	HP:0100851	Abnormal emotion/affect behavior	67	2.918196e-2	1.000000e+0	1.000000e+0	3.426774e+1	2.918196e-2	1	2.918196e-2	1.000000e+0	61	1.402361e-2	1.000000e+0	1.000000e+0	7.130830e+1	1.402361e-2	1	253	1.000000e+0	3.952569e-3	unnamed	SUCLA2
Human Phenotype	HP:0000508	Ptosis	68	2.965278e-2	1.000000e+0	1.000000e+0	3.372365e+1	2.965278e-2	1	2.965278e-2	1.000000e+0	66	1.568649e-2	1.000000e+0	1.000000e+0	6.374912e+1	1.568649e-2	1	283	1.000000e+0	3.533569e-3	unnamed	SUCLA2
Human Phenotype	HP:0010993	Abnormality of the cerebral subcortex	69	3.078375e-2	1.000000e+0	1.000000e+0	3.248468e+1	3.078375e-2	1	3.078375e-2	1.000000e+0	64	1.491048e-2	1.000000e+0	1.000000e+0	6.706691e+1	1.491048e-2	1	269	1.000000e+0	3.717472e-3	unnamed	SUCLA2
Human Phenotype	HP:0011968	Feeding difficulties	70	3.142552e-2	1.000000e+0	1.000000e+0	3.182127e+1	3.142552e-2	1	3.142552e-2	1.000000e+0	68	1.618536e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	292	1.000000e+0	3.424658e-3	unnamed	SUCLA2
Human Phenotype	HP:0002118	Abnormality of the cerebral ventricles	71	3.540846e-2	1.000000e+0	1.000000e+0	2.824184e+1	3.540846e-2	1	3.540846e-2	1.000000e+0	70	1.707222e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	308	1.000000e+0	3.246753e-3	unnamed	SUCLA2
Human Phenotype	HP:0011362	Abnormal hair quantity	72	3.605802e-2	1.000000e+0	1.000000e+0	2.773308e+1	3.605802e-2	1	3.605802e-2	1.000000e+0	72	1.768195e-2	1.000000e+0	1.000000e+0	5.655486e+1	1.768195e-2	1	319	1.000000e+0	3.134796e-3	unnamed	SUCLA2
Human Phenotype	HP:0001276	Hypertonia	73	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	75	2.089685e-2	1.000000e+0	1.000000e+0	4.785411e+1	2.089685e-2	1	377	1.000000e+0	2.652520e-3	unnamed	SUCLA2
Human Phenotype	HP:0001288	Gait disturbance	74	3.682158e-2	1.000000e+0	1.000000e+0	2.715798e+1	3.682158e-2	1	3.682158e-2	1.000000e+0	73	1.818081e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	328	1.000000e+0	3.048780e-3	unnamed	SUCLA2
Human Phenotype	HP:0011277	Abnormality of the urinary system physiology	75	3.851912e-2	1.000000e+0	1.000000e+0	2.596113e+1	3.851912e-2	1	3.851912e-2	1.000000e+0	77	2.339116e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	422	1.000000e+0	2.369668e-3	unnamed	SUCLA2
Human Phenotype	HP:0001324	Muscle weakness	76	3.916358e-2	1.000000e+0	1.000000e+0	2.553393e+1	3.916358e-2	1	3.916358e-2	1.000000e+0	80	2.372374e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	428	1.000000e+0	2.336449e-3	unnamed	SUCLA2
Human Phenotype	HP:0002795	Functional respiratory abnormality	77	4.088885e-2	1.000000e+0	1.000000e+0	2.445654e+1	4.088885e-2	1	4.088885e-2	1.000000e+0	79	2.361288e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	426	1.000000e+0	2.347418e-3	unnamed	SUCLA2
Human Phenotype	HP:0011443	Abnormality of coordination	78	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	76	2.267058e-2	1.000000e+0	1.000000e+0	4.411002e+1	2.267058e-2	1	409	1.000000e+0	2.444988e-3	unnamed	SUCLA2
Human Phenotype	HP:0000479	Abnormality of the retina	79	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	82	2.444432e-2	1.000000e+0	1.000000e+0	4.090930e+1	2.444432e-2	1	441	1.000000e+0	2.267574e-3	unnamed	SUCLA2
Human Phenotype	HP:0000486	Strabismus	80	4.438473e-2	1.000000e+0	1.000000e+0	2.253027e+1	4.438473e-2	1	4.438473e-2	1.000000e+0	74	2.034255e-2	1.000000e+0	1.000000e+0	4.915804e+1	2.034255e-2	1	367	1.000000e+0	2.724796e-3	unnamed	SUCLA2
Human Phenotype	HP:0000505	Visual impairment	81	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	83	2.466604e-2	1.000000e+0	1.000000e+0	4.054157e+1	2.466604e-2	1	445	1.000000e+0	2.247191e-3	unnamed	SUCLA2
Human Phenotype	HP:0004325	Decreased body weight	82	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	83	2.466604e-2	1.000000e+0	1.000000e+0	4.054157e+1	2.466604e-2	1	445	1.000000e+0	2.247191e-3	unnamed	SUCLA2
Human Phenotype	HP:0000252	Microcephaly	83	4.655716e-2	1.000000e+0	1.000000e+0	2.147897e+1	4.655716e-2	1	4.655716e-2	1.000000e+0	78	2.355745e-2	1.000000e+0	1.000000e+0	4.244941e+1	2.355745e-2	1	425	1.000000e+0	2.352941e-3	unnamed	SUCLA2
Human Phenotype	HP:0000407	Sensorineural hearing impairment	84	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	81	2.405632e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	434	1.000000e+0	2.304147e-3	unnamed	SUCLA2
Human Phenotype	HP:0000759	Abnormality of the peripheral nervous system	85	4.946470e-2	1.000000e+0	1.000000e+0	2.021644e+1	4.946470e-2	1	4.946470e-2	1.000000e+0	87	2.632892e-2	1.000000e+0	1.000000e+0	3.798105e+1	2.632892e-2	1	475	1.000000e+0	2.105263e-3	unnamed	SUCLA2
Human Phenotype	HP:0000504	Abnormality of vision	86	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	88	2.743750e-2	1.000000e+0	1.000000e+0	3.644646e+1	2.743750e-2	1	495	1.000000e+0	2.020202e-3	unnamed	SUCLA2
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	87	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	85	2.499861e-2	1.000000e+0	1.000000e+0	4.000222e+1	2.499861e-2	1	451	1.000000e+0	2.217295e-3	unnamed	SUCLA2
Human Phenotype	HP:0000359	Abnormality of the inner ear	88	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	86	2.522033e-2	1.000000e+0	1.000000e+0	3.965055e+1	2.522033e-2	1	455	1.000000e+0	2.197802e-3	unnamed	SUCLA2
Human Phenotype	HP:0011007	Age of onset	89	5.358267e-2	1.000000e+0	1.000000e+0	1.866275e+1	5.358267e-2	1	5.358267e-2	1.000000e+0	96	3.242614e-2	1.000000e+0	1.000000e+0	3.083932e+1	3.242614e-2	1	585	1.000000e+0	1.709402e-3	unnamed	SUCLA2
Human Phenotype	HP:0003674	Onset	90	5.502040e-2	1.000000e+0	1.000000e+0	1.817508e+1	5.502040e-2	1	5.502040e-2	1.000000e+0	101	3.320215e-2	1.000000e+0	1.000000e+0	3.011853e+1	3.320215e-2	1	599	1.000000e+0	1.669449e-3	unnamed	SUCLA2
Human Phenotype	HP:0007364	Aplasia/Hypoplasia of the cerebrum	91	5.539730e-2	1.000000e+0	1.000000e+0	1.805142e+1	5.539730e-2	1	5.539730e-2	1.000000e+0	90	2.882324e-2	1.000000e+0	1.000000e+0	3.469423e+1	2.882324e-2	1	520	1.000000e+0	1.923077e-3	unnamed	SUCLA2
Human Phenotype	HP:0001595	Abnormality of the hair	92	5.637295e-2	1.000000e+0	1.000000e+0	1.773901e+1	5.637295e-2	1	5.637295e-2	1.000000e+0	89	2.793637e-2	1.000000e+0	1.000000e+0	3.579563e+1	2.793637e-2	1	504	1.000000e+0	1.984127e-3	unnamed	SUCLA2
Human Phenotype	HP:0011458	Abdominal symptom	93	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	91	3.048611e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	550	1.000000e+0	1.818182e-3	unnamed	SUCLA2
Human Phenotype	HP:0001263	Global developmental delay	94	5.775253e-2	1.000000e+0	1.000000e+0	1.731526e+1	5.775253e-2	1	5.775253e-2	1.000000e+0	97	3.248157e-2	1.000000e+0	1.000000e+0	3.078669e+1	3.248157e-2	1	586	1.000000e+0	1.706485e-3	unnamed	SUCLA2
Human Phenotype	HP:0000496	Abnormality of eye movement	95	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	92	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	SUCLA2
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	96	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	98	3.286957e-2	1.000000e+0	1.000000e+0	3.042327e+1	3.286957e-2	1	593	1.000000e+0	1.686341e-3	unnamed	SUCLA2
Human Phenotype	HP:0002088	Abnormality of the lung	97	5.867133e-2	1.000000e+0	1.000000e+0	1.704410e+1	5.867133e-2	1	5.867133e-2	1.000000e+0	110	3.558561e-2	1.000000e+0	1.000000e+0	2.810125e+1	3.558561e-2	1	642	1.000000e+0	1.557632e-3	unnamed	SUCLA2
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	98	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	99	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	SUCLA2
Human Phenotype	HP:0001098	Abnormality of the fundus	99	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	99	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	SUCLA2
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	100	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	102	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	SUCLA2
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	101	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	92	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	SUCLA2
Human Phenotype	HP:0004322	Short stature	102	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	94	3.148384e-2	1.000000e+0	1.000000e+0	3.176232e+1	3.148384e-2	1	568	1.000000e+0	1.760563e-3	unnamed	SUCLA2
Human Phenotype	HP:0011805	Abnormality of muscle morphology	103	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	109	3.530846e-2	1.000000e+0	1.000000e+0	2.832182e+1	3.530846e-2	1	637	1.000000e+0	1.569859e-3	unnamed	SUCLA2
Human Phenotype	HP:0000240	Abnormality of skull size	104	6.394702e-2	1.000000e+0	1.000000e+0	1.563795e+1	6.394702e-2	1	6.394702e-2	1.000000e+0	95	3.203814e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	578	1.000000e+0	1.730104e-3	unnamed	SUCLA2
Human Phenotype	HP:0004323	Abnormality of body weight	105	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	102	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	SUCLA2
Human Phenotype	HP:0001252	Muscular hypotonia	106	6.484906e-2	1.000000e+0	1.000000e+0	1.542042e+1	6.484906e-2	1	6.484906e-2	1.000000e+0	105	3.370101e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	608	1.000000e+0	1.644737e-3	unnamed	SUCLA2
Human Phenotype	HP:0003808	Abnormal muscle tone	107	6.512600e-2	1.000000e+0	1.000000e+0	1.535485e+1	6.512600e-2	1	6.512600e-2	1.000000e+0	106	3.375644e-2	1.000000e+0	1.000000e+0	2.962397e+1	3.375644e-2	1	609	1.000000e+0	1.642036e-3	unnamed	SUCLA2
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	108	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	111	3.641705e-2	1.000000e+0	1.000000e+0	2.745967e+1	3.641705e-2	1	657	1.000000e+0	1.522070e-3	unnamed	SUCLA2
Human Phenotype	HP:0000002	Abnormality of body height	109	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	106	3.375644e-2	1.000000e+0	1.000000e+0	2.962397e+1	3.375644e-2	1	609	1.000000e+0	1.642036e-3	unnamed	SUCLA2
Human Phenotype	HP:0011138	Abnormality of skin adnexa	110	6.863693e-2	1.000000e+0	1.000000e+0	1.456942e+1	6.863693e-2	1	6.863693e-2	1.000000e+0	108	3.458788e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	624	1.000000e+0	1.602564e-3	unnamed	SUCLA2
Human Phenotype	HP:0100022	Abnormality of movement	111	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	112	3.652791e-2	1.000000e+0	1.000000e+0	2.737633e+1	3.652791e-2	1	659	1.000000e+0	1.517451e-3	unnamed	SUCLA2
Human Phenotype	HP:0001249	Intellectual disability	112	7.044946e-2	1.000000e+0	1.000000e+0	1.419457e+1	7.044946e-2	1	7.044946e-2	1.000000e+0	104	3.331301e-2	1.000000e+0	1.000000e+0	3.001830e+1	3.331301e-2	1	601	1.000000e+0	1.663894e-3	unnamed	SUCLA2
Human Phenotype	HP:0000365	Hearing impairment	113	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	113	3.719306e-2	1.000000e+0	1.000000e+0	2.688674e+1	3.719306e-2	1	671	1.000000e+0	1.490313e-3	unnamed	SUCLA2
Human Phenotype	HP:0000364	Hearing abnormality	114	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	114	3.796907e-2	1.000000e+0	1.000000e+0	2.633723e+1	3.796907e-2	1	685	1.000000e+0	1.459854e-3	unnamed	SUCLA2
Human Phenotype	HP:0002060	Abnormality of the cerebrum	115	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	115	4.018624e-2	1.000000e+0	1.000000e+0	2.488414e+1	4.018624e-2	1	725	1.000000e+0	1.379310e-3	unnamed	SUCLA2
Human Phenotype	HP:0100547	Abnormality of the forebrain	116	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	117	4.040796e-2	1.000000e+0	1.000000e+0	2.474760e+1	4.040796e-2	1	729	1.000000e+0	1.371742e-3	unnamed	SUCLA2
Human Phenotype	HP:0001510	Growth delay	117	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	115	4.018624e-2	1.000000e+0	1.000000e+0	2.488414e+1	4.018624e-2	1	725	1.000000e+0	1.379310e-3	unnamed	SUCLA2
Human Phenotype	HP:0001250	Seizures	118	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	118	4.195998e-2	1.000000e+0	1.000000e+0	2.383223e+1	4.195998e-2	1	757	1.000000e+0	1.321004e-3	unnamed	SUCLA2
Human Phenotype	HP:0011442	Abnormality of central motor function	119	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	120	4.484230e-2	1.000000e+0	1.000000e+0	2.230037e+1	4.484230e-2	1	809	1.000000e+0	1.236094e-3	unnamed	SUCLA2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	120	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	119	4.428801e-2	1.000000e+0	1.000000e+0	2.257947e+1	4.428801e-2	1	799	1.000000e+0	1.251564e-3	unnamed	SUCLA2
Human Phenotype	HP:0000004	Onset and clinical course	121	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	124	5.071781e-2	1.000000e+0	1.000000e+0	1.971694e+1	5.071781e-2	1	915	1.000000e+0	1.092896e-3	unnamed	SUCLA2
Human Phenotype	HP:0002086	Abnormality of the respiratory system	122	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	122	4.794634e-2	1.000000e+0	1.000000e+0	2.085665e+1	4.794634e-2	1	865	1.000000e+0	1.156069e-3	unnamed	SUCLA2
Human Phenotype	HP:0000079	Abnormality of the urinary system	123	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	121	4.633889e-2	1.000000e+0	1.000000e+0	2.158014e+1	4.633889e-2	1	836	1.000000e+0	1.196172e-3	unnamed	SUCLA2
Human Phenotype	HP:0012443	Abnormality of the brain	124	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	123	5.044066e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	910	1.000000e+0	1.098901e-3	unnamed	SUCLA2
Human Phenotype	HP:0011804	Abnormality of muscle physiology	125	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	126	5.398814e-2	1.000000e+0	1.000000e+0	1.852259e+1	5.398814e-2	1	974	1.000000e+0	1.026694e-3	unnamed	SUCLA2
Human Phenotype	HP:0000929	Abnormality of the skull	126	1.006699e-1	1.000000e+0	1.000000e+0	9.933458e+0	1.006699e-1	1	1.006699e-1	1.000000e+0	125	5.143839e-2	1.000000e+0	1.000000e+0	1.944073e+1	5.143839e-2	1	928	1.000000e+0	1.077586e-3	unnamed	SUCLA2
Human Phenotype	HP:0000598	Abnormality of the ear	127	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	127	5.459786e-2	1.000000e+0	1.000000e+0	1.831574e+1	5.459786e-2	1	985	1.000000e+0	1.015228e-3	unnamed	SUCLA2
Human Phenotype	HP:0012373	Abnormal eye physiology	128	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	128	5.858877e-2	1.000000e+0	1.000000e+0	1.706812e+1	5.858877e-2	1	1057	1.000000e+0	9.460738e-4	unnamed	SUCLA2
Human Phenotype	HP:0012374	Abnormality of the globe	129	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	129	5.875506e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	1060	1.000000e+0	9.433962e-4	unnamed	SUCLA2
Human Phenotype	HP:0012372	Abnormal eye morphology	130	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	131	6.058422e-2	1.000000e+0	1.000000e+0	1.650595e+1	6.058422e-2	1	1093	1.000000e+0	9.149131e-4	unnamed	SUCLA2
Human Phenotype	HP:0001507	Growth abnormality	131	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	130	5.980821e-2	1.000000e+0	1.000000e+0	1.672011e+1	5.980821e-2	1	1079	1.000000e+0	9.267841e-4	unnamed	SUCLA2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	132	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	132	6.241339e-2	1.000000e+0	1.000000e+0	1.602220e+1	6.241339e-2	1	1126	1.000000e+0	8.880995e-4	unnamed	SUCLA2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	133	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	140	7.344382e-2	1.000000e+0	1.000000e+0	1.361585e+1	7.344382e-2	1	1325	1.000000e+0	7.547170e-4	unnamed	SUCLA2
Human Phenotype	HP:0003011	Abnormality of the musculature	134	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	134	6.446428e-2	1.000000e+0	1.000000e+0	1.551247e+1	6.446428e-2	1	1163	1.000000e+0	8.598452e-4	unnamed	SUCLA2
Human Phenotype	HP:0001438	Abnormality of the abdomen	135	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	136	6.806718e-2	1.000000e+0	1.000000e+0	1.469137e+1	6.806718e-2	1	1228	1.000000e+0	8.143322e-4	unnamed	SUCLA2
Human Phenotype	HP:0001574	Abnormality of the integument	136	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	135	6.784546e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	1224	1.000000e+0	8.169935e-4	unnamed	SUCLA2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	137	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	137	6.839976e-2	1.000000e+0	1.000000e+0	1.461994e+1	6.839976e-2	1	1234	1.000000e+0	8.103728e-4	unnamed	SUCLA2
Human Phenotype	HP:0009121	Abnormal axial skeleton morphology	138	1.232157e-1	1.000000e+0	1.000000e+0	8.115849e+0	1.232157e-1	1	1.232157e-1	1.000000e+0	133	6.280140e-2	1.000000e+0	1.000000e+0	1.592321e+1	6.280140e-2	1	1133	1.000000e+0	8.826125e-4	unnamed	SUCLA2
Human Phenotype	HP:0100543	Cognitive impairment	139	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	138	6.878776e-2	1.000000e+0	1.000000e+0	1.453747e+1	6.878776e-2	1	1241	1.000000e+0	8.058018e-4	unnamed	SUCLA2
Human Phenotype	HP:0000271	Abnormality of the face	140	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	139	7.039521e-2	1.000000e+0	1.000000e+0	1.420551e+1	7.039521e-2	1	1270	1.000000e+0	7.874016e-4	unnamed	SUCLA2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	141	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	147	8.924117e-2	1.000000e+0	1.000000e+0	1.120559e+1	8.924117e-2	1	1610	1.000000e+0	6.211180e-4	unnamed	SUCLA2
Human Phenotype	HP:0000478	Abnormality of the eye	142	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	141	7.715759e-2	1.000000e+0	1.000000e+0	1.296049e+1	7.715759e-2	1	1392	1.000000e+0	7.183908e-4	unnamed	SUCLA2
Human Phenotype	HP:0011446	Abnormality of higher mental function	143	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	142	7.843246e-2	1.000000e+0	1.000000e+0	1.274982e+1	7.843246e-2	1	1415	1.000000e+0	7.067138e-4	unnamed	SUCLA2
Human Phenotype	HP:0000234	Abnormality of the head	144	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	144	7.893132e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	1424	1.000000e+0	7.022472e-4	unnamed	SUCLA2
Human Phenotype	HP:0000152	Abnormality of head and neck	145	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	145	8.031706e-2	1.000000e+0	1.000000e+0	1.245066e+1	8.031706e-2	1	1449	1.000000e+0	6.901311e-4	unnamed	SUCLA2
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	146	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	143	7.882046e-2	1.000000e+0	1.000000e+0	1.268706e+1	7.882046e-2	1	1422	1.000000e+0	7.032349e-4	unnamed	SUCLA2
Human Phenotype	HP:0000924	Abnormality of the skeletal system	147	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	146	8.103764e-2	1.000000e+0	1.000000e+0	1.233995e+1	8.103764e-2	1	1462	1.000000e+0	6.839945e-4	unnamed	SUCLA2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	148	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	148	9.567097e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	1726	1.000000e+0	5.793743e-4	unnamed	SUCLA2
Human Phenotype	HP:0000707	Abnormality of the nervous system	149	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	149	1.001607e-1	1.000000e+0	1.000000e+0	9.983951e+0	1.001607e-1	1	1807	1.000000e+0	5.534034e-4	unnamed	SUCLA2
Human Phenotype	HP:0000005	Mode of inheritance	150	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	150	1.452248e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	2620	1.000000e+0	3.816794e-4	unnamed	SUCLA2
Human Phenotype	HP:0000118	Phenotypic abnormality	151	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	151	1.548140e-1	1.000000e+0	1.000000e+0	6.459363e+0	1.548140e-1	1	2793	1.000000e+0	3.580380e-4	unnamed	SUCLA2
Human Phenotype	HP:0000001	All	152	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	152	1.564215e-1	1.000000e+0	1.000000e+0	6.392984e+0	1.564215e-1	1	2822	1.000000e+0	3.543586e-4	unnamed	SUCLA2
MSigDB Cancer Neighborhood	MORF_MSH2	Neighborhood of MSH2	1	3.253665e-3	1.000000e+0	1.000000e+0	3.073457e+2	3.253665e-3	1	3.253665e-3	1.000000e+0	1	3.325758e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	SUCLA2
MSigDB Cancer Neighborhood	MORF_EIF4E	Neighborhood of EIF4E	2	5.941204e-3	1.000000e+0	1.000000e+0	1.683161e+2	5.941204e-3	1	5.941204e-3	1.000000e+0	2	4.656061e-3	1.000000e+0	9.940690e-1	2.147738e+2	4.656061e-3	1	84	1.000000e+0	1.190476e-2	unnamed	SUCLA2
MSigDB Cancer Neighborhood	MORF_HDAC2	Neighborhood of HDAC2	3	2.010072e-2	1.000000e+0	1.000000e+0	4.974947e+1	2.010072e-2	1	2.010072e-2	1.000000e+0	3	1.540935e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	278	1.000000e+0	3.597122e-3	unnamed	SUCLA2
BioCyc Pathway	PWY66-398	TCA cycle	1	1.635672e-3	5.430431e-1	5.430431e-1	6.113695e+2	1.635672e-3	1	1.635672e-3	1.000000e+0	1	9.422981e-4	3.128430e-1	3.128430e-1	1.061235e+3	9.422981e-4	1	17	1.000000e+0	5.882353e-2	unnamed	SUCLA2
BioCyc Pathway	PWY66-407	conversion of glucose to acetyl CoA and entry into the TCA cycle	2	3.845972e-3	1.000000e+0	6.384314e-1	2.600123e+2	3.845972e-3	1	3.845972e-3	1.000000e+0	2	2.549748e-3	8.465163e-1	4.232582e-1	3.921957e+2	2.549748e-3	1	46	1.000000e+0	2.173913e-2	unnamed	SUCLA2
MSigDB Pathway	BIOCARTA_KREB_PATHWAY	The Citric Acid Cycle	1	7.169279e-4	9.463448e-1	9.463448e-1	1.394840e+3	7.169279e-4	1	7.169279e-4	1.000000e+0	1	4.434344e-4	5.853334e-1	5.853334e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	SUCLA2
MSigDB Pathway	REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE	Genes involved in Citric acid cycle (TCA cycle)	2	1.992023e-3	1.000000e+0	1.000000e+0	5.020022e+2	1.992023e-3	1	1.992023e-3	1.000000e+0	2	1.053157e-3	1.000000e+0	6.950836e-1	9.495263e+2	1.053157e-3	1	19	1.000000e+0	5.263158e-2	unnamed	SUCLA2
MSigDB Pathway	KEGG_CITRATE_CYCLE_TCA_CYCLE	Citrate cycle (TCA cycle)	3	3.135785e-3	1.000000e+0	1.000000e+0	3.188994e+2	3.135785e-3	1	3.135785e-3	1.000000e+0	3	1.662879e-3	1.000000e+0	7.316668e-1	6.013667e+2	1.662879e-3	1	30	1.000000e+0	3.333333e-2	unnamed	SUCLA2
MSigDB Pathway	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE	Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle	4	3.406097e-3	1.000000e+0	1.000000e+0	2.935912e+2	3.406097e-3	1	3.406097e-3	1.000000e+0	5	2.217172e-3	1.000000e+0	5.853334e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	SUCLA2
MSigDB Pathway	KEGG_PROPANOATE_METABOLISM	Propanoate metabolism	5	3.439668e-3	1.000000e+0	9.080724e-1	2.907257e+2	3.439668e-3	1	3.439668e-3	1.000000e+0	4	1.773738e-3	1.000000e+0	5.853335e-1	5.637812e+2	1.773738e-3	1	32	1.000000e+0	3.125000e-2	unnamed	SUCLA2
MSigDB Pathway	REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT	Genes involved in The citric acid (TCA) cycle and respiratory electron transport	6	8.121454e-3	1.000000e+0	1.000000e+0	1.231307e+2	8.121454e-3	1	8.121454e-3	1.000000e+0	6	7.150380e-3	1.000000e+0	1.000000e+0	1.398527e+2	7.150380e-3	1	129	1.000000e+0	7.751938e-3	unnamed	SUCLA2
MGI Expression: Detected	14208	TS22_skeletal muscle	1	1.727748e-2	1.000000e+0	1.000000e+0	5.787881e+1	1.727748e-2	1	1.727748e-2	1.000000e+0	1	8.924117e-3	1.000000e+0	1.000000e+0	1.120559e+2	8.924117e-3	1	161	1.000000e+0	6.211180e-3	unnamed	SUCLA2
MGI Expression: Detected	9065	TS23_right lung	2	2.909097e-2	1.000000e+0	1.000000e+0	3.437493e+1	2.909097e-2	1	2.909097e-2	1.000000e+0	2	1.385732e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	250	1.000000e+0	4.000000e-3	unnamed	SUCLA2
MGI Expression: Detected	9061	TS23_left lung	3	2.930295e-2	1.000000e+0	1.000000e+0	3.412625e+1	2.930295e-2	1	2.930295e-2	1.000000e+0	3	1.391275e-2	1.000000e+0	1.000000e+0	7.187649e+1	1.391275e-2	1	251	1.000000e+0	3.984064e-3	unnamed	SUCLA2
MGI Expression: Detected	14331	TS22_gonad	4	7.009554e-2	1.000000e+0	1.000000e+0	1.426624e+1	7.009554e-2	1	7.009554e-2	1.000000e+0	5	3.342387e-2	1.000000e+0	1.000000e+0	2.991874e+1	3.342387e-2	1	603	1.000000e+0	1.658375e-3	unnamed	SUCLA2
MGI Expression: Detected	15072	TS22_meninges	5	7.865579e-2	1.000000e+0	1.000000e+0	1.271362e+1	7.865579e-2	1	7.865579e-2	1.000000e+0	6	3.602904e-2	1.000000e+0	1.000000e+0	2.775538e+1	3.602904e-2	1	650	1.000000e+0	1.538462e-3	unnamed	SUCLA2
MGI Expression: Detected	14321	TS22_blood vessel	6	8.078372e-2	1.000000e+0	1.000000e+0	1.237873e+1	8.078372e-2	1	8.078372e-2	1.000000e+0	4	3.159470e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	570	1.000000e+0	1.754386e-3	unnamed	SUCLA2
MGI Expression: Detected	6061	TS22_thyroid gland	7	8.180205e-2	1.000000e+0	1.000000e+0	1.222463e+1	8.180205e-2	1	8.180205e-2	1.000000e+0	13	4.151655e-2	1.000000e+0	1.000000e+0	2.408678e+1	4.151655e-2	1	749	1.000000e+0	1.335113e-3	unnamed	SUCLA2
MGI Expression: Detected	5956	TS22_middle ear	8	8.347899e-2	1.000000e+0	1.000000e+0	1.197906e+1	8.347899e-2	1	8.347899e-2	1.000000e+0	8	3.785821e-2	1.000000e+0	1.000000e+0	2.641435e+1	3.785821e-2	1	683	1.000000e+0	1.464129e-3	unnamed	SUCLA2
MGI Expression: Detected	15543	TS22_muscle	9	8.686886e-2	1.000000e+0	1.000000e+0	1.151161e+1	8.686886e-2	1	8.686886e-2	1.000000e+0	11	4.029710e-2	1.000000e+0	1.000000e+0	2.481568e+1	4.029710e-2	1	727	1.000000e+0	1.375516e-3	unnamed	SUCLA2
MGI Expression: Detected	15562	TS22_appendicular skeleton	10	8.712548e-2	1.000000e+0	1.000000e+0	1.147770e+1	8.712548e-2	1	8.712548e-2	1.000000e+0	7	3.780278e-2	1.000000e+0	1.000000e+0	2.645308e+1	3.780278e-2	1	682	1.000000e+0	1.466276e-3	unnamed	SUCLA2
MGI Expression: Detected	15561	TS22_urethra	11	9.613757e-2	1.000000e+0	1.000000e+0	1.040176e+1	9.613757e-2	1	9.613757e-2	1.000000e+0	12	4.079596e-2	1.000000e+0	1.000000e+0	2.451223e+1	4.079596e-2	1	736	1.000000e+0	1.358696e-3	unnamed	SUCLA2
MGI Expression: Detected	6274	TS22_larynx	12	9.645471e-2	1.000000e+0	1.000000e+0	1.036756e+1	9.645471e-2	1	9.645471e-2	1.000000e+0	9	3.807993e-2	1.000000e+0	1.000000e+0	2.626055e+1	3.807993e-2	1	687	1.000000e+0	1.455604e-3	unnamed	SUCLA2
MGI Expression: Detected	7379	TS22_adrenal gland	13	9.915582e-2	1.000000e+0	1.000000e+0	1.008514e+1	9.915582e-2	1	9.915582e-2	1.000000e+0	15	4.439887e-2	1.000000e+0	1.000000e+0	2.252310e+1	4.439887e-2	1	801	1.000000e+0	1.248439e-3	unnamed	SUCLA2
MGI Expression: Detected	15553	TS22_piriform cortex	14	1.032521e-1	1.000000e+0	1.000000e+0	9.685029e+0	1.032521e-1	1	1.032521e-1	1.000000e+0	10	3.963195e-2	1.000000e+0	1.000000e+0	2.523217e+1	3.963195e-2	1	715	1.000000e+0	1.398601e-3	unnamed	SUCLA2
MGI Expression: Detected	15555	TS22_pallidum	15	1.064133e-1	1.000000e+0	1.000000e+0	9.397318e+0	1.064133e-1	1	1.064133e-1	1.000000e+0	18	4.717033e-2	1.000000e+0	1.000000e+0	2.119976e+1	4.717033e-2	1	851	1.000000e+0	1.175088e-3	unnamed	SUCLA2
MGI Expression: Detected	5821	TS22_heart ventricle	16	1.076795e-1	1.000000e+0	1.000000e+0	9.286823e+0	1.076795e-1	1	1.076795e-1	1.000000e+0	17	4.628347e-2	1.000000e+0	1.000000e+0	2.160599e+1	4.628347e-2	1	835	1.000000e+0	1.197605e-3	unnamed	SUCLA2
MGI Expression: Detected	9938	TS23_vagus X ganglion	17	1.091809e-1	1.000000e+0	1.000000e+0	9.159115e+0	1.091809e-1	1	1.091809e-1	1.000000e+0	29	5.360013e-2	1.000000e+0	1.000000e+0	1.865667e+1	5.360013e-2	1	967	1.000000e+0	1.034126e-3	unnamed	SUCLA2
MGI Expression: Detected	6186	TS22_palatal shelf	18	1.101205e-1	1.000000e+0	1.000000e+0	9.080962e+0	1.101205e-1	1	1.101205e-1	1.000000e+0	14	4.234799e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	764	1.000000e+0	1.308901e-3	unnamed	SUCLA2
MGI Expression: Detected	5796	TS22_heart atrium	19	1.107744e-1	1.000000e+0	1.000000e+0	9.027353e+0	1.107744e-1	1	1.107744e-1	1.000000e+0	20	4.778006e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	862	1.000000e+0	1.160093e-3	unnamed	SUCLA2
MGI Expression: Detected	14882	TS22_choroid plexus	20	1.113392e-1	1.000000e+0	1.000000e+0	8.981559e+0	1.113392e-1	1	1.113392e-1	1.000000e+0	28	5.265783e-2	1.000000e+0	1.000000e+0	1.899053e+1	5.265783e-2	1	950	1.000000e+0	1.052632e-3	unnamed	SUCLA2
MGI Expression: Detected	15549	TS22_amygdala	21	1.158880e-1	1.000000e+0	1.000000e+0	8.629023e+0	1.158880e-1	1	1.158880e-1	1.000000e+0	19	4.744748e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	856	1.000000e+0	1.168224e-3	unnamed	SUCLA2
MGI Expression: Detected	6324	TS22_urinary bladder	22	1.164763e-1	1.000000e+0	1.000000e+0	8.585439e+0	1.164763e-1	1	1.164763e-1	1.000000e+0	22	4.888864e-2	1.000000e+0	1.000000e+0	2.045465e+1	4.888864e-2	1	882	1.000000e+0	1.133787e-3	unnamed	SUCLA2
MGI Expression: Detected	15546	TS22_hair	23	1.175256e-1	1.000000e+0	1.000000e+0	8.508786e+0	1.175256e-1	1	1.175256e-1	1.000000e+0	30	5.437614e-2	1.000000e+0	1.000000e+0	1.839042e+1	5.437614e-2	1	981	1.000000e+0	1.019368e-3	unnamed	SUCLA2
MGI Expression: Detected	6369	TS22_pituitary gland	24	1.180244e-1	1.000000e+0	1.000000e+0	8.472823e+0	1.180244e-1	1	1.180244e-1	1.000000e+0	23	4.894407e-2	1.000000e+0	1.000000e+0	2.043148e+1	4.894407e-2	1	883	1.000000e+0	1.132503e-3	unnamed	SUCLA2
MGI Expression: Detected	6180	TS22_upper jaw	25	1.194250e-1	1.000000e+0	1.000000e+0	8.373458e+0	1.194250e-1	1	1.194250e-1	1.000000e+0	16	4.600632e-2	1.000000e+0	1.000000e+0	2.173614e+1	4.600632e-2	1	830	1.000000e+0	1.204819e-3	unnamed	SUCLA2
MGI Expression: Detected	7865	TS23_lung	26	1.197260e-1	1.000000e+0	1.000000e+0	8.352401e+0	1.197260e-1	1	1.197260e-1	1.000000e+0	31	5.504129e-2	1.000000e+0	1.000000e+0	1.816818e+1	5.504129e-2	1	993	1.000000e+0	1.007049e-3	unnamed	SUCLA2
MGI Expression: Detected	15544	TS22_haemolymphoid system	27	1.219806e-1	1.000000e+0	1.000000e+0	8.198027e+0	1.219806e-1	1	1.219806e-1	1.000000e+0	35	5.886592e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	1062	1.000000e+0	9.416196e-4	unnamed	SUCLA2
MGI Expression: Detected	6068	TS22_thymus primordium	28	1.222946e-1	1.000000e+0	1.000000e+0	8.176977e+0	1.222946e-1	1	1.222946e-1	1.000000e+0	41	6.263511e-2	1.000000e+0	1.000000e+0	1.596549e+1	6.263511e-2	1	1130	1.000000e+0	8.849558e-4	unnamed	SUCLA2
MGI Expression: Detected	6090	TS22_oesophagus	29	1.223668e-1	1.000000e+0	1.000000e+0	8.172154e+0	1.223668e-1	1	1.223668e-1	1.000000e+0	25	5.154925e-2	1.000000e+0	1.000000e+0	1.939892e+1	5.154925e-2	1	930	1.000000e+0	1.075269e-3	unnamed	SUCLA2
MGI Expression: Detected	15557	TS22_pretectum	30	1.224320e-1	1.000000e+0	1.000000e+0	8.167802e+0	1.224320e-1	1	1.224320e-1	1.000000e+0	23	4.894407e-2	1.000000e+0	1.000000e+0	2.043148e+1	4.894407e-2	1	883	1.000000e+0	1.132503e-3	unnamed	SUCLA2
MGI Expression: Detected	15548	TS22_vibrissa follicle	31	1.227087e-1	1.000000e+0	1.000000e+0	8.149379e+0	1.227087e-1	1	1.227087e-1	1.000000e+0	32	5.542930e-2	1.000000e+0	1.000000e+0	1.804100e+1	5.542930e-2	1	1000	1.000000e+0	1.000000e-3	unnamed	SUCLA2
MGI Expression: Detected	15547	TS22_hair follicle	32	1.240608e-1	1.000000e+0	1.000000e+0	8.060566e+0	1.240608e-1	1	1.240608e-1	1.000000e+0	33	5.642703e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	1018	1.000000e+0	9.823183e-4	unnamed	SUCLA2
MGI Expression: Detected	5945	TS22_labyrinth	33	1.278308e-1	1.000000e+0	1.000000e+0	7.822840e+0	1.278308e-1	1	1.278308e-1	1.000000e+0	26	5.199268e-2	1.000000e+0	1.000000e+0	1.923348e+1	5.199268e-2	1	938	1.000000e+0	1.066098e-3	unnamed	SUCLA2
MGI Expression: Detected	10087	TS23_facial VII ganglion	34	1.289780e-1	1.000000e+0	1.000000e+0	7.753260e+0	1.289780e-1	1	1.289780e-1	1.000000e+0	36	5.958650e-2	1.000000e+0	1.000000e+0	1.678233e+1	5.958650e-2	1	1075	1.000000e+0	9.302326e-4	unnamed	SUCLA2
MGI Expression: Detected	6842	TS22_axial skeleton	35	1.303760e-1	1.000000e+0	1.000000e+0	7.670126e+0	1.303760e-1	1	1.303760e-1	1.000000e+0	34	5.709218e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	1030	1.000000e+0	9.708738e-4	unnamed	SUCLA2
MGI Expression: Detected	15542	TS22_face	36	1.307291e-1	1.000000e+0	1.000000e+0	7.649405e+0	1.307291e-1	1	1.307291e-1	1.000000e+0	21	4.805720e-2	1.000000e+0	1.000000e+0	2.080854e+1	4.805720e-2	1	867	1.000000e+0	1.153403e-3	unnamed	SUCLA2
MGI Expression: Detected	6060	TS22_foregut gland	37	1.353133e-1	1.000000e+0	1.000000e+0	7.390259e+0	1.353133e-1	1	1.353133e-1	1.000000e+0	50	6.767918e-2	1.000000e+0	1.000000e+0	1.477559e+1	6.767918e-2	1	1221	1.000000e+0	8.190008e-4	unnamed	SUCLA2
MGI Expression: Detected	6151	TS22_salivary gland	38	1.368294e-1	1.000000e+0	1.000000e+0	7.308370e+0	1.368294e-1	1	1.368294e-1	1.000000e+0	61	7.006264e-2	1.000000e+0	1.000000e+0	1.427294e+1	7.006264e-2	1	1264	1.000000e+0	7.911392e-4	unnamed	SUCLA2
MGI Expression: Detected	7164	TS22_head	39	1.382999e-1	1.000000e+0	1.000000e+0	7.230661e+0	1.382999e-1	1	1.382999e-1	1.000000e+0	27	5.243612e-2	1.000000e+0	1.000000e+0	1.907082e+1	5.243612e-2	1	946	1.000000e+0	1.057082e-3	unnamed	SUCLA2
MGI Expression: Detected	15556	TS22_telencephalon septum	40	1.394228e-1	1.000000e+0	1.000000e+0	7.172430e+0	1.394228e-1	1	1.394228e-1	1.000000e+0	37	6.036251e-2	1.000000e+0	1.000000e+0	1.656657e+1	6.036251e-2	1	1089	1.000000e+0	9.182736e-4	unnamed	SUCLA2
MGI Expression: Detected	14382	TS22_tooth	41	1.399558e-1	1.000000e+0	1.000000e+0	7.145113e+0	1.399558e-1	1	1.399558e-1	1.000000e+0	42	6.269054e-2	1.000000e+0	1.000000e+0	1.595137e+1	6.269054e-2	1	1131	1.000000e+0	8.841733e-4	unnamed	SUCLA2
MGI Expression: Detected	14381	TS22_jaw	42	1.400172e-1	1.000000e+0	1.000000e+0	7.141978e+0	1.400172e-1	1	1.400172e-1	1.000000e+0	43	6.280140e-2	1.000000e+0	1.000000e+0	1.592321e+1	6.280140e-2	1	1133	1.000000e+0	8.826125e-4	unnamed	SUCLA2
MGI Expression: Detected	6283	TS22_liver	43	1.413531e-1	1.000000e+0	1.000000e+0	7.074480e+0	1.413531e-1	1	1.413531e-1	1.000000e+0	89	8.020620e-2	1.000000e+0	1.000000e+0	1.246786e+1	8.020620e-2	1	1447	1.000000e+0	6.910850e-4	unnamed	SUCLA2
MGI Expression: Detected	14126	TS22_skin	44	1.465811e-1	1.000000e+0	1.000000e+0	6.822160e+0	1.465811e-1	1	1.465811e-1	1.000000e+0	52	6.801175e-2	1.000000e+0	1.000000e+0	1.470334e+1	6.801175e-2	1	1227	1.000000e+0	8.149959e-4	unnamed	SUCLA2
MGI Expression: Detected	6007	TS22_olfactory epithelium	45	1.474473e-1	1.000000e+0	1.000000e+0	6.782086e+0	1.474473e-1	1	1.474473e-1	1.000000e+0	53	6.817804e-2	1.000000e+0	1.000000e+0	1.466748e+1	6.817804e-2	1	1230	1.000000e+0	8.130081e-4	unnamed	SUCLA2
MGI Expression: Detected	15560	TS22_superior colliculus	46	1.477563e-1	1.000000e+0	1.000000e+0	6.767903e+0	1.477563e-1	1	1.477563e-1	1.000000e+0	45	6.512943e-2	1.000000e+0	1.000000e+0	1.535404e+1	6.512943e-2	1	1175	1.000000e+0	8.510638e-4	unnamed	SUCLA2
MGI Expression: Detected	6048	TS22_pancreas	47	1.480883e-1	1.000000e+0	1.000000e+0	6.752730e+0	1.480883e-1	1	1.480883e-1	1.000000e+0	74	7.488498e-2	1.000000e+0	1.000000e+0	1.335381e+1	7.488498e-2	1	1351	1.000000e+0	7.401925e-4	unnamed	SUCLA2
MGI Expression: Detected	7620	TS23_respiratory system	48	1.491012e-1	1.000000e+0	1.000000e+0	6.706855e+0	1.491012e-1	1	1.491012e-1	1.000000e+0	49	6.740203e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	1216	1.000000e+0	8.223684e-4	unnamed	SUCLA2
MGI Expression: Detected	5922	TS22_cochlea	49	1.492632e-1	1.000000e+0	1.000000e+0	6.699575e+0	1.492632e-1	1	1.492632e-1	1.000000e+0	38	6.169281e-2	1.000000e+0	1.000000e+0	1.620934e+1	6.169281e-2	1	1113	1.000000e+0	8.984726e-4	unnamed	SUCLA2
MGI Expression: Detected	5919	TS22_saccule	50	1.498929e-1	1.000000e+0	1.000000e+0	6.671430e+0	1.498929e-1	1	1.498929e-1	1.000000e+0	39	6.196996e-2	1.000000e+0	1.000000e+0	1.613685e+1	6.196996e-2	1	1118	1.000000e+0	8.944544e-4	unnamed	SUCLA2
MGI Expression: Detected	6006	TS22_nasal cavity epithelium	51	1.515001e-1	1.000000e+0	1.000000e+0	6.600654e+0	1.515001e-1	1	1.515001e-1	1.000000e+0	57	6.917577e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	1248	1.000000e+0	8.012821e-4	unnamed	SUCLA2
MGI Expression: Detected	15559	TS22_inferior colliculus	52	1.515672e-1	1.000000e+0	1.000000e+0	6.597735e+0	1.515672e-1	1	1.515672e-1	1.000000e+0	58	6.961920e-2	1.000000e+0	1.000000e+0	1.436385e+1	6.961920e-2	1	1256	1.000000e+0	7.961783e-4	unnamed	SUCLA2
MGI Expression: Detected	5915	TS22_inner ear vestibular component	53	1.520718e-1	1.000000e+0	1.000000e+0	6.575842e+0	1.520718e-1	1	1.520718e-1	1.000000e+0	40	6.241339e-2	1.000000e+0	1.000000e+0	1.602220e+1	6.241339e-2	1	1126	1.000000e+0	8.880995e-4	unnamed	SUCLA2
MGI Expression: Detected	9930	TS23_glossopharyngeal IX ganglion	54	1.524650e-1	1.000000e+0	1.000000e+0	6.558883e+0	1.524650e-1	1	1.524650e-1	1.000000e+0	72	7.416440e-2	1.000000e+0	1.000000e+0	1.348356e+1	7.416440e-2	1	1338	1.000000e+0	7.473842e-4	unnamed	SUCLA2
MGI Expression: Detected	6005	TS22_nasal cavity	55	1.531636e-1	1.000000e+0	1.000000e+0	6.528965e+0	1.531636e-1	1	1.531636e-1	1.000000e+0	59	6.984092e-2	1.000000e+0	1.000000e+0	1.431825e+1	6.984092e-2	1	1260	1.000000e+0	7.936508e-4	unnamed	SUCLA2
MGI Expression: Detected	14294	TS22_intestine	56	1.532463e-1	1.000000e+0	1.000000e+0	6.525444e+0	1.532463e-1	1	1.532463e-1	1.000000e+0	60	6.989635e-2	1.000000e+0	1.000000e+0	1.430690e+1	6.989635e-2	1	1261	1.000000e+0	7.930214e-4	unnamed	SUCLA2
MGI Expression: Detected	15554	TS22_olfactory bulb	57	1.538523e-1	1.000000e+0	1.000000e+0	6.499740e+0	1.538523e-1	1	1.538523e-1	1.000000e+0	54	6.845519e-2	1.000000e+0	1.000000e+0	1.460810e+1	6.845519e-2	1	1235	1.000000e+0	8.097166e-4	unnamed	SUCLA2
MGI Expression: Detected	6422	TS22_corpus striatum	58	1.541272e-1	1.000000e+0	1.000000e+0	6.488146e+0	1.541272e-1	1	1.541272e-1	1.000000e+0	48	6.734660e-2	1.000000e+0	1.000000e+0	1.484856e+1	6.734660e-2	1	1215	1.000000e+0	8.230453e-4	unnamed	SUCLA2
MGI Expression: Detected	14796	TS22_genital tubercle	59	1.568692e-1	1.000000e+0	1.000000e+0	6.374736e+0	1.568692e-1	1	1.568692e-1	1.000000e+0	44	6.440885e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	1162	1.000000e+0	8.605852e-4	unnamed	SUCLA2
MGI Expression: Detected	6073	TS22_tongue	60	1.571634e-1	1.000000e+0	1.000000e+0	6.362804e+0	1.571634e-1	1	1.571634e-1	1.000000e+0	45	6.512943e-2	1.000000e+0	1.000000e+0	1.535404e+1	6.512943e-2	1	1175	1.000000e+0	8.510638e-4	unnamed	SUCLA2
MGI Expression: Detected	5786	TS22_heart	61	1.580825e-1	1.000000e+0	1.000000e+0	6.325810e+0	1.580825e-1	1	1.580825e-1	1.000000e+0	51	6.773460e-2	1.000000e+0	1.000000e+0	1.476350e+1	6.773460e-2	1	1222	1.000000e+0	8.183306e-4	unnamed	SUCLA2
MGI Expression: Detected	15551	TS22_neocortex	62	1.592728e-1	1.000000e+0	1.000000e+0	6.278537e+0	1.592728e-1	1	1.592728e-1	1.000000e+0	71	7.405354e-2	1.000000e+0	1.000000e+0	1.350374e+1	7.405354e-2	1	1336	1.000000e+0	7.485030e-4	unnamed	SUCLA2
MGI Expression: Detected	6004	TS22_nose	63	1.592731e-1	1.000000e+0	1.000000e+0	6.278524e+0	1.592731e-1	1	1.592731e-1	1.000000e+0	64	7.189180e-2	1.000000e+0	1.000000e+0	1.390979e+1	7.189180e-2	1	1297	1.000000e+0	7.710100e-4	unnamed	SUCLA2
MGI Expression: Detected	15552	TS22_hippocampus	64	1.594696e-1	1.000000e+0	1.000000e+0	6.270789e+0	1.594696e-1	1	1.594696e-1	1.000000e+0	66	7.272324e-2	1.000000e+0	1.000000e+0	1.375076e+1	7.272324e-2	1	1312	1.000000e+0	7.621951e-4	unnamed	SUCLA2
MGI Expression: Detected	6430	TS22_olfactory cortex	65	1.608863e-1	1.000000e+0	1.000000e+0	6.215568e+0	1.608863e-1	1	1.608863e-1	1.000000e+0	63	7.078322e-2	1.000000e+0	1.000000e+0	1.412764e+1	7.078322e-2	1	1277	1.000000e+0	7.830854e-4	unnamed	SUCLA2
MGI Expression: Detected	6096	TS22_stomach	66	1.611981e-1	1.000000e+0	1.000000e+0	6.203548e+0	1.611981e-1	1	1.611981e-1	1.000000e+0	69	7.344382e-2	1.000000e+0	1.000000e+0	1.361585e+1	7.344382e-2	1	1325	1.000000e+0	7.547170e-4	unnamed	SUCLA2
MGI Expression: Detected	6443	TS22_cerebellum	67	1.613687e-1	1.000000e+0	1.000000e+0	6.196990e+0	1.613687e-1	1	1.613687e-1	1.000000e+0	47	6.623801e-2	1.000000e+0	1.000000e+0	1.509707e+1	6.623801e-2	1	1195	1.000000e+0	8.368201e-4	unnamed	SUCLA2
MGI Expression: Detected	6530	TS22_dorsal root ganglion	68	1.626980e-1	1.000000e+0	1.000000e+0	6.146356e+0	1.626980e-1	1	1.626980e-1	1.000000e+0	81	7.749016e-2	1.000000e+0	1.000000e+0	1.290486e+1	7.749016e-2	1	1398	1.000000e+0	7.153076e-4	unnamed	SUCLA2
MGI Expression: Detected	6529	TS22_spinal ganglion	69	1.629789e-1	1.000000e+0	1.000000e+0	6.135764e+0	1.629789e-1	1	1.629789e-1	1.000000e+0	83	7.776731e-2	1.000000e+0	1.000000e+0	1.285887e+1	7.776731e-2	1	1403	1.000000e+0	7.127584e-4	unnamed	SUCLA2
MGI Expression: Detected	6069	TS22_pharynx	70	1.630132e-1	1.000000e+0	1.000000e+0	6.134472e+0	1.630132e-1	1	1.630132e-1	1.000000e+0	55	6.906491e-2	1.000000e+0	1.000000e+0	1.447913e+1	6.906491e-2	1	1246	1.000000e+0	8.025682e-4	unnamed	SUCLA2
MGI Expression: Detected	6528	TS22_peripheral nervous system spinal component	71	1.635087e-1	1.000000e+0	1.000000e+0	6.115881e+0	1.635087e-1	1	1.635087e-1	1.000000e+0	84	7.798902e-2	1.000000e+0	1.000000e+0	1.282232e+1	7.798902e-2	1	1407	1.000000e+0	7.107321e-4	unnamed	SUCLA2
MGI Expression: Detected	15558	TS22_tectum	72	1.647681e-1	1.000000e+0	1.000000e+0	6.069134e+0	1.647681e-1	1	1.647681e-1	1.000000e+0	77	7.577185e-2	1.000000e+0	1.000000e+0	1.319751e+1	7.577185e-2	1	1367	1.000000e+0	7.315289e-4	unnamed	SUCLA2
MGI Expression: Detected	6353	TS22_cranial ganglion	73	1.651063e-1	1.000000e+0	1.000000e+0	6.056703e+0	1.651063e-1	1	1.651063e-1	1.000000e+0	78	7.599357e-2	1.000000e+0	1.000000e+0	1.315901e+1	7.599357e-2	1	1371	1.000000e+0	7.293946e-4	unnamed	SUCLA2
MGI Expression: Detected	6352	TS22_central nervous system ganglion	74	1.659118e-1	1.000000e+0	1.000000e+0	6.027299e+0	1.659118e-1	1	1.659118e-1	1.000000e+0	79	7.610443e-2	1.000000e+0	1.000000e+0	1.313984e+1	7.610443e-2	1	1373	1.000000e+0	7.283321e-4	unnamed	SUCLA2
MGI Expression: Detected	6429	TS22_olfactory lobe	75	1.669790e-1	1.000000e+0	1.000000e+0	5.988777e+0	1.669790e-1	1	1.669790e-1	1.000000e+0	67	7.305582e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	1318	1.000000e+0	7.587253e-4	unnamed	SUCLA2
MGI Expression: Detected	6764	TS22_tail	76	1.685274e-1	1.000000e+0	1.000000e+0	5.933752e+0	1.685274e-1	1	1.685274e-1	1.000000e+0	73	7.427526e-2	1.000000e+0	1.000000e+0	1.346343e+1	7.427526e-2	1	1340	1.000000e+0	7.462687e-4	unnamed	SUCLA2
MGI Expression: Detected	6489	TS22_midbrain tegmentum	77	1.686133e-1	1.000000e+0	1.000000e+0	5.930730e+0	1.686133e-1	1	1.686133e-1	1.000000e+0	68	7.333296e-2	1.000000e+0	1.000000e+0	1.363643e+1	7.333296e-2	1	1323	1.000000e+0	7.558579e-4	unnamed	SUCLA2
MGI Expression: Detected	15550	TS22_basal ganglia	78	1.686432e-1	1.000000e+0	1.000000e+0	5.929677e+0	1.686432e-1	1	1.686432e-1	1.000000e+0	76	7.560557e-2	1.000000e+0	1.000000e+0	1.322654e+1	7.560557e-2	1	1364	1.000000e+0	7.331378e-4	unnamed	SUCLA2
MGI Expression: Detected	5785	TS22_cardiovascular system	79	1.703620e-1	1.000000e+0	1.000000e+0	5.869853e+0	1.703620e-1	1	1.703620e-1	1.000000e+0	70	7.394269e-2	1.000000e+0	1.000000e+0	1.352399e+1	7.394269e-2	1	1334	1.000000e+0	7.496252e-4	unnamed	SUCLA2
MGI Expression: Detected	6841	TS22_skeleton	80	1.708206e-1	1.000000e+0	1.000000e+0	5.854096e+0	1.708206e-1	1	1.708206e-1	1.000000e+0	86	7.909761e-2	1.000000e+0	1.000000e+0	1.264261e+1	7.909761e-2	1	1427	1.000000e+0	7.007708e-4	unnamed	SUCLA2
MGI Expression: Detected	7372	TS22_gland	81	1.711188e-1	1.000000e+0	1.000000e+0	5.843894e+0	1.711188e-1	1	1.711188e-1	1.000000e+0	87	7.970733e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	1438	1.000000e+0	6.954103e-4	unnamed	SUCLA2
MGI Expression: Detected	5911	TS22_inner ear	82	1.714490e-1	1.000000e+0	1.000000e+0	5.832639e+0	1.714490e-1	1	1.714490e-1	1.000000e+0	62	7.072779e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	1276	1.000000e+0	7.836991e-4	unnamed	SUCLA2
MGI Expression: Detected	5972	TS22_retina	83	1.739957e-1	1.000000e+0	1.000000e+0	5.747269e+0	1.739957e-1	1	1.739957e-1	1.000000e+0	85	7.882046e-2	1.000000e+0	1.000000e+0	1.268706e+1	7.882046e-2	1	1422	1.000000e+0	7.032349e-4	unnamed	SUCLA2
MGI Expression: Detected	6392	TS22_hypothalamus	84	1.772777e-1	1.000000e+0	1.000000e+0	5.640869e+0	1.772777e-1	1	1.772777e-1	1.000000e+0	56	6.912034e-2	1.000000e+0	1.000000e+0	1.446752e+1	6.912034e-2	1	1247	1.000000e+0	8.019246e-4	unnamed	SUCLA2
MGI Expression: Detected	6448	TS22_pons	85	1.774012e-1	1.000000e+0	1.000000e+0	5.636940e+0	1.774012e-1	1	1.774012e-1	1.000000e+0	75	7.494041e-2	1.000000e+0	1.000000e+0	1.334393e+1	7.494041e-2	1	1352	1.000000e+0	7.396450e-4	unnamed	SUCLA2
MGI Expression: Detected	6456	TS22_medulla oblongata	86	1.800456e-1	1.000000e+0	1.000000e+0	5.554150e+0	1.800456e-1	1	1.800456e-1	1.000000e+0	82	7.771188e-2	1.000000e+0	1.000000e+0	1.286805e+1	7.771188e-2	1	1402	1.000000e+0	7.132668e-4	unnamed	SUCLA2
MGI Expression: Detected	6396	TS22_thalamus	87	1.800705e-1	1.000000e+0	1.000000e+0	5.553382e+0	1.800705e-1	1	1.800705e-1	1.000000e+0	65	7.200266e-2	1.000000e+0	1.000000e+0	1.388838e+1	7.200266e-2	1	1299	1.000000e+0	7.698229e-4	unnamed	SUCLA2
MGI Expression: Detected	5910	TS22_ear	88	1.803802e-1	1.000000e+0	1.000000e+0	5.543845e+0	1.803802e-1	1	1.803802e-1	1.000000e+0	80	7.671415e-2	1.000000e+0	1.000000e+0	1.303540e+1	7.671415e-2	1	1384	1.000000e+0	7.225434e-4	unnamed	SUCLA2
MGI Expression: Detected	6527	TS22_peripheral nervous system	89	1.812151e-1	1.000000e+0	1.000000e+0	5.518303e+0	1.812151e-1	1	1.812151e-1	1.000000e+0	94	8.486226e-2	1.000000e+0	1.000000e+0	1.178380e+1	8.486226e-2	1	1531	1.000000e+0	6.531679e-4	unnamed	SUCLA2
MGI Expression: Detected	9925	TS23_dorsal root ganglion	90	1.818204e-1	1.000000e+0	1.000000e+0	5.499934e+0	1.818204e-1	1	1.818204e-1	1.000000e+0	93	8.469597e-2	1.000000e+0	1.000000e+0	1.180694e+1	8.469597e-2	1	1528	1.000000e+0	6.544503e-4	unnamed	SUCLA2
MGI Expression: Detected	8795	TS23_spinal ganglion	91	1.822471e-1	1.000000e+0	1.000000e+0	5.487056e+0	1.822471e-1	1	1.822471e-1	1.000000e+0	96	8.519483e-2	1.000000e+0	1.000000e+0	1.173780e+1	8.519483e-2	1	1537	1.000000e+0	6.506181e-4	unnamed	SUCLA2
MGI Expression: Detected	7849	TS23_peripheral nervous system spinal component	92	1.829940e-1	1.000000e+0	1.000000e+0	5.464660e+0	1.829940e-1	1	1.829940e-1	1.000000e+0	97	8.552741e-2	1.000000e+0	1.000000e+0	1.169216e+1	8.552741e-2	1	1543	1.000000e+0	6.480881e-4	unnamed	SUCLA2
MGI Expression: Detected	6568	TS22_integumental system	93	1.850874e-1	1.000000e+0	1.000000e+0	5.402852e+0	1.850874e-1	1	1.850874e-1	1.000000e+0	95	8.491769e-2	1.000000e+0	1.000000e+0	1.177611e+1	8.491769e-2	1	1532	1.000000e+0	6.527415e-4	unnamed	SUCLA2
MGI Expression: Detected	6304	TS22_metanephros	94	1.870028e-1	1.000000e+0	1.000000e+0	5.347512e+0	1.870028e-1	1	1.870028e-1	1.000000e+0	98	8.646971e-2	1.000000e+0	1.000000e+0	1.156474e+1	8.646971e-2	1	1560	1.000000e+0	6.410256e-4	unnamed	SUCLA2
MGI Expression: Detected	6585	TS22_forelimb	95	1.870231e-1	1.000000e+0	1.000000e+0	5.346934e+0	1.870231e-1	1	1.870231e-1	1.000000e+0	88	7.981819e-2	1.000000e+0	1.000000e+0	1.252847e+1	7.981819e-2	1	1440	1.000000e+0	6.944444e-4	unnamed	SUCLA2
MGI Expression: Detected	6673	TS22_hindlimb	96	1.911455e-1	1.000000e+0	1.000000e+0	5.231616e+0	1.911455e-1	1	1.911455e-1	1.000000e+0	90	8.281137e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	1494	1.000000e+0	6.693440e-4	unnamed	SUCLA2
MGI Expression: Detected	9934	TS23_trigeminal V ganglion	97	1.922888e-1	1.000000e+0	1.000000e+0	5.200510e+0	1.922888e-1	1	1.922888e-1	1.000000e+0	99	8.791087e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	1586	1.000000e+0	6.305170e-4	unnamed	SUCLA2
MGI Expression: Detected	6221	TS22_lung	98	1.938574e-1	1.000000e+0	1.000000e+0	5.158431e+0	1.938574e-1	1	1.938574e-1	1.000000e+0	108	9.334294e-2	1.000000e+0	1.000000e+0	1.071318e+1	9.334294e-2	1	1684	1.000000e+0	5.938242e-4	unnamed	SUCLA2
MGI Expression: Detected	6327	TS22_reproductive system	99	1.969804e-1	1.000000e+0	1.000000e+0	5.076647e+0	1.969804e-1	1	1.969804e-1	1.000000e+0	100	8.852059e-2	1.000000e+0	1.000000e+0	1.129681e+1	8.852059e-2	1	1597	1.000000e+0	6.261741e-4	unnamed	SUCLA2
MGI Expression: Detected	7616	TS23_peripheral nervous system	100	1.978285e-1	1.000000e+0	1.000000e+0	5.054883e+0	1.978285e-1	1	1.978285e-1	1.000000e+0	103	9.212350e-2	1.000000e+0	1.000000e+0	1.085499e+1	9.212350e-2	1	1662	1.000000e+0	6.016847e-4	unnamed	SUCLA2
MGI Expression: Detected	6438	TS22_metencephalon lateral wall	101	1.987443e-1	1.000000e+0	1.000000e+0	5.031590e+0	1.987443e-1	1	1.987443e-1	1.000000e+0	91	8.447425e-2	1.000000e+0	1.000000e+0	1.183793e+1	8.447425e-2	1	1524	1.000000e+0	6.561680e-4	unnamed	SUCLA2
MGI Expression: Detected	6437	TS22_metencephalon	102	1.993050e-1	1.000000e+0	1.000000e+0	5.017434e+0	1.993050e-1	1	1.993050e-1	1.000000e+0	92	8.464054e-2	1.000000e+0	1.000000e+0	1.181467e+1	8.464054e-2	1	1527	1.000000e+0	6.548788e-4	unnamed	SUCLA2
MGI Expression: Detected	6511	TS22_spinal cord	103	1.995992e-1	1.000000e+0	1.000000e+0	5.010039e+0	1.995992e-1	1	1.995992e-1	1.000000e+0	102	9.001718e-2	1.000000e+0	1.000000e+0	1.110899e+1	9.001718e-2	1	1624	1.000000e+0	6.157635e-4	unnamed	SUCLA2
MGI Expression: Detected	6477	TS22_midbrain	104	2.050250e-1	1.000000e+0	1.000000e+0	4.877454e+0	2.050250e-1	1	2.050250e-1	1.000000e+0	105	9.278865e-2	1.000000e+0	1.000000e+0	1.077718e+1	9.278865e-2	1	1674	1.000000e+0	5.973716e-4	unnamed	SUCLA2
MGI Expression: Detected	8791	TS23_cranial ganglion	105	2.058991e-1	1.000000e+0	1.000000e+0	4.856747e+0	2.058991e-1	1	2.058991e-1	1.000000e+0	104	9.240064e-2	1.000000e+0	1.000000e+0	1.082244e+1	9.240064e-2	1	1667	1.000000e+0	5.998800e-4	unnamed	SUCLA2
MGI Expression: Detected	7845	TS23_central nervous system ganglion	106	2.070222e-1	1.000000e+0	1.000000e+0	4.830399e+0	2.070222e-1	1	2.070222e-1	1.000000e+0	107	9.289951e-2	1.000000e+0	1.000000e+0	1.076432e+1	9.289951e-2	1	1676	1.000000e+0	5.966587e-4	unnamed	SUCLA2
MGI Expression: Detected	6220	TS22_respiratory system	107	2.099993e-1	1.000000e+0	1.000000e+0	4.761920e+0	2.099993e-1	1	2.099993e-1	1.000000e+0	112	9.932931e-2	1.000000e+0	1.000000e+0	1.006752e+1	9.932931e-2	1	1792	1.000000e+0	5.580357e-4	unnamed	SUCLA2
MGI Expression: Detected	6149	TS22_oral region	108	2.100630e-1	1.000000e+0	1.000000e+0	4.760476e+0	2.100630e-1	1	2.100630e-1	1.000000e+0	111	9.733385e-2	1.000000e+0	1.000000e+0	1.027392e+1	9.733385e-2	1	1756	1.000000e+0	5.694761e-4	unnamed	SUCLA2
MGI Expression: Detected	5964	TS22_eye	109	2.101319e-1	1.000000e+0	1.000000e+0	4.758916e+0	2.101319e-1	1	2.101319e-1	1.000000e+0	110	9.639155e-2	1.000000e+0	1.000000e+0	1.037435e+1	9.639155e-2	1	1739	1.000000e+0	5.750431e-4	unnamed	SUCLA2
MGI Expression: Detected	6434	TS22_hindbrain	110	2.130295e-1	1.000000e+0	1.000000e+0	4.694185e+0	2.130295e-1	1	2.130295e-1	1.000000e+0	105	9.278865e-2	1.000000e+0	1.000000e+0	1.077718e+1	9.278865e-2	1	1674	1.000000e+0	5.973716e-4	unnamed	SUCLA2
MGI Expression: Detected	6584	TS22_limb	111	2.158969e-1	1.000000e+0	1.000000e+0	4.631841e+0	2.158969e-1	1	2.158969e-1	1.000000e+0	109	9.339837e-2	1.000000e+0	1.000000e+0	1.070682e+1	9.339837e-2	1	1685	1.000000e+0	5.934718e-4	unnamed	SUCLA2
MGI Expression: Detected	6367	TS22_diencephalon	112	2.176277e-1	1.000000e+0	1.000000e+0	4.595004e+0	2.176277e-1	1	2.176277e-1	1.000000e+0	101	8.874231e-2	1.000000e+0	1.000000e+0	1.126858e+1	8.874231e-2	1	1601	1.000000e+0	6.246096e-4	unnamed	SUCLA2
MGI Expression: Detected	6059	TS22_foregut	113	2.181768e-1	1.000000e+0	1.000000e+0	4.583440e+0	2.181768e-1	1	2.181768e-1	1.000000e+0	113	1.037082e-1	1.000000e+0	1.000000e+0	9.642437e+0	1.037082e-1	1	1871	1.000000e+0	5.344735e-4	unnamed	SUCLA2
MGI Expression: Detected	6301	TS22_renal-urinary system	114	2.309447e-1	1.000000e+0	1.000000e+0	4.330041e+0	2.309447e-1	1	2.309447e-1	1.000000e+0	114	1.070894e-1	1.000000e+0	1.000000e+0	9.337992e+0	1.070894e-1	1	1932	1.000000e+0	5.175983e-4	unnamed	SUCLA2
MGI Expression: Detected	6415	TS22_cerebral cortex	115	2.536664e-1	1.000000e+0	1.000000e+0	3.942185e+0	2.536664e-1	1	2.536664e-1	1.000000e+0	115	1.130203e-1	1.000000e+0	1.000000e+0	8.847965e+0	1.130203e-1	1	2039	1.000000e+0	4.904365e-4	unnamed	SUCLA2
MGI Expression: Detected	6020	TS22_gut	116	2.671263e-1	1.000000e+0	1.000000e+0	3.743547e+0	2.671263e-1	1	2.671263e-1	1.000000e+0	119	1.328640e-1	1.000000e+0	1.000000e+0	7.526491e+0	1.328640e-1	1	2397	1.000000e+0	4.171882e-4	unnamed	SUCLA2
MGI Expression: Detected	5909	TS22_sensory organ	117	2.701558e-1	1.000000e+0	1.000000e+0	3.701567e+0	2.701558e-1	1	2.701558e-1	1.000000e+0	117	1.251594e-1	1.000000e+0	1.000000e+0	7.989814e+0	1.251594e-1	1	2258	1.000000e+0	4.428698e-4	unnamed	SUCLA2
MGI Expression: Detected	6405	TS22_telencephalon	118	2.740885e-1	1.000000e+0	1.000000e+0	3.648457e+0	2.740885e-1	1	2.740885e-1	1.000000e+0	116	1.215010e-1	1.000000e+0	1.000000e+0	8.230383e+0	1.215010e-1	1	2192	1.000000e+0	4.562044e-4	unnamed	SUCLA2
MGI Expression: Detected	6366	TS22_forebrain	119	2.941681e-1	1.000000e+0	1.000000e+0	3.399417e+0	2.941681e-1	1	2.941681e-1	1.000000e+0	118	1.314229e-1	1.000000e+0	1.000000e+0	7.609026e+0	1.314229e-1	1	2371	1.000000e+0	4.217630e-4	unnamed	SUCLA2
MGI Expression: Detected	6019	TS22_alimentary system	120	2.958102e-1	1.000000e+0	1.000000e+0	3.380547e+0	2.958102e-1	1	2.958102e-1	1.000000e+0	120	1.512111e-1	1.000000e+0	1.000000e+0	6.613270e+0	1.512111e-1	1	2728	1.000000e+0	3.665689e-4	unnamed	SUCLA2
MGI Expression: Detected	6018	TS22_visceral organ	121	3.446359e-1	1.000000e+0	1.000000e+0	2.901613e+0	3.446359e-1	1	3.446359e-1	1.000000e+0	124	1.827504e-1	1.000000e+0	1.000000e+0	5.471944e+0	1.827504e-1	1	3297	1.000000e+0	3.033060e-4	unnamed	SUCLA2
MGI Expression: Detected	6365	TS22_brain	122	3.486991e-1	1.000000e+0	1.000000e+0	2.867802e+0	3.486991e-1	1	3.486991e-1	1.000000e+0	121	1.615764e-1	1.000000e+0	1.000000e+0	6.189022e+0	1.615764e-1	1	2915	1.000000e+0	3.430532e-4	unnamed	SUCLA2
MGI Expression: Detected	6351	TS22_central nervous system	123	3.611614e-1	1.000000e+0	1.000000e+0	2.768845e+0	3.611614e-1	1	3.611614e-1	1.000000e+0	122	1.699462e-1	1.000000e+0	1.000000e+0	5.884214e+0	1.699462e-1	1	3066	1.000000e+0	3.261579e-4	unnamed	SUCLA2
MGI Expression: Detected	6350	TS22_nervous system	124	3.685477e-1	1.000000e+0	1.000000e+0	2.713353e+0	3.685477e-1	1	3.685477e-1	1.000000e+0	123	1.757663e-1	1.000000e+0	1.000000e+0	5.689372e+0	1.757663e-1	1	3171	1.000000e+0	3.153579e-4	unnamed	SUCLA2
MGI Expression: Detected	5784	TS22_organ system	125	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	125	2.553074e-1	1.000000e+0	1.000000e+0	3.916848e+0	2.553074e-1	1	4606	1.000000e+0	2.171081e-4	unnamed	SUCLA2
MGI Expression: Detected	5741	TS22_embryo	126	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	128	2.755390e-1	1.000000e+0	1.000000e+0	3.629250e+0	2.755390e-1	1	4971	1.000000e+0	2.011668e-4	unnamed	SUCLA2
MGI Expression: Detected	5740	Theiler_stage_22	127	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	129	2.768694e-1	1.000000e+0	1.000000e+0	3.611812e+0	2.768694e-1	1	4995	1.000000e+0	2.002002e-4	unnamed	SUCLA2
MGI Expression: Detected	7489	TS23_visceral organ	128	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	130	3.083532e-1	1.000000e+0	1.000000e+0	3.243034e+0	3.083532e-1	1	5563	1.000000e+0	1.797591e-4	unnamed	SUCLA2
MGI Expression: Detected	7608	TS23_central nervous system	129	5.265571e-1	1.000000e+0	1.000000e+0	1.899129e+0	5.265571e-1	1	5.265571e-1	1.000000e+0	126	2.658389e-1	1.000000e+0	1.000000e+0	3.761676e+0	2.658389e-1	1	4796	1.000000e+0	2.085071e-4	unnamed	SUCLA2
MGI Expression: Detected	7501	TS23_nervous system	130	5.331601e-1	1.000000e+0	1.000000e+0	1.875609e+0	5.331601e-1	1	5.331601e-1	1.000000e+0	127	2.710493e-1	1.000000e+0	1.000000e+0	3.689366e+0	2.710493e-1	1	4890	1.000000e+0	2.044990e-4	unnamed	SUCLA2
MGI Expression: Detected	7445	TS23_organ system	131	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	131	4.466493e-1	1.000000e+0	1.000000e+0	2.238893e+0	4.466493e-1	1	8058	1.000000e+0	1.241003e-4	unnamed	SUCLA2
MGI Expression: Detected	6925	TS23_embryo	132	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	132	4.840086e-1	1.000000e+0	1.000000e+0	2.066079e+0	4.840086e-1	1	8732	1.000000e+0	1.145213e-4	unnamed	SUCLA2
MGI Expression: Detected	6924	Theiler_stage_23	133	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	133	4.841749e-1	1.000000e+0	1.000000e+0	2.065369e+0	4.841749e-1	1	8735	1.000000e+0	1.144820e-4	unnamed	SUCLA2
MSigDB Perturbation	MOOTHA_TCA	Tricarboxylic acid related genes; based on literature and sequence annotation resources and converted to Affymetrix HG-U133A probe sets.	1	1.272809e-3	1.000000e+0	1.000000e+0	7.856636e+2	1.272809e-3	1	1.272809e-3	1.000000e+0	1	8.868688e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	SUCLA2
MSigDB Perturbation	ABBUD_LIF_SIGNALING_1_DN	Genes down-regulated in AtT20 cells (pituitary cancer) after  treatment with LIF [GeneID=3976].	2	3.747331e-3	1.000000e+0	1.000000e+0	2.668566e+2	3.747331e-3	1	3.747331e-3	1.000000e+0	2	1.385732e-3	1.000000e+0	1.000000e+0	7.216400e+2	1.385732e-3	1	25	1.000000e+0	4.000000e-2	unnamed	SUCLA2
MSigDB Perturbation	LIN_MELANOMA_COPY_NUMBER_DN	Candidate genes in significant regions of chromosomal copy number losses in a panel of melanoma samples.	3	5.047413e-3	1.000000e+0	1.000000e+0	1.981213e+2	5.047413e-3	1	5.047413e-3	1.000000e+0	3	2.217172e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	SUCLA2
MSigDB Perturbation	CHANG_IMMORTALIZED_BY_HPV31_UP	Genes up-regulated in normal keratinocytes immortalized by infection with the high risk HPV31 (human papilloma virus) strain.	4	8.788077e-3	1.000000e+0	1.000000e+0	1.137905e+2	8.788077e-3	1	8.788077e-3	1.000000e+0	4	4.046339e-3	1.000000e+0	1.000000e+0	2.471370e+2	4.046339e-3	1	73	1.000000e+0	1.369863e-2	unnamed	SUCLA2
MSigDB Perturbation	GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	Genes up-regulated in quiescent CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors compared to the dividing cells from CML (chronic myeloid leukemia) patients.	5	1.595697e-2	1.000000e+0	1.000000e+0	6.266855e+1	1.595697e-2	1	1.595697e-2	1.000000e+0	6	9.977274e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	180	1.000000e+0	5.555556e-3	unnamed	SUCLA2
MSigDB Perturbation	WONG_MITOCHONDRIA_GENE_MODULE	Genes that comprise the mitochondria gene module	6	1.597954e-2	1.000000e+0	1.000000e+0	6.258004e+1	1.597954e-2	1	1.597954e-2	1.000000e+0	7	1.213902e-2	1.000000e+0	1.000000e+0	8.237900e+1	1.213902e-2	1	219	1.000000e+0	4.566210e-3	unnamed	SUCLA2
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_6HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 6h.	7	2.009742e-2	1.000000e+0	1.000000e+0	4.975762e+1	2.009742e-2	1	2.009742e-2	1.000000e+0	5	8.979547e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	162	1.000000e+0	6.172840e-3	unnamed	SUCLA2
MSigDB Perturbation	DANG_REGULATED_BY_MYC_DN	Genes down-regulated by MYC [GeneID=4609], according to the MYC Target Gene Database.	8	2.709890e-2	1.000000e+0	1.000000e+0	3.690186e+1	2.709890e-2	1	2.709890e-2	1.000000e+0	8	1.413447e-2	1.000000e+0	1.000000e+0	7.074902e+1	1.413447e-2	1	255	1.000000e+0	3.921569e-3	unnamed	SUCLA2
MSigDB Perturbation	MOOTHA_PGC	Genes up-regulated in differentiating C2C12 cells (myoblasts) upon expression of PPARGC1A [GeneID=10891] off an adenoviral vector.	9	2.877022e-2	1.000000e+0	1.000000e+0	3.475816e+1	2.877022e-2	1	2.877022e-2	1.000000e+0	13	2.333574e-2	1.000000e+0	1.000000e+0	4.285273e+1	2.333574e-2	1	421	1.000000e+0	2.375297e-3	unnamed	SUCLA2
MSigDB Perturbation	MOOTHA_HUMAN_MITODB_6_2002	Mitochondrial genes; based on literature and sequence annotation resources and converted to Affymetrix HG-U133A probe sets.	10	3.082442e-2	1.000000e+0	1.000000e+0	3.244181e+1	3.082442e-2	1	3.082442e-2	1.000000e+0	14	2.383460e-2	1.000000e+0	1.000000e+0	4.195581e+1	2.383460e-2	1	430	1.000000e+0	2.325581e-3	unnamed	SUCLA2
MSigDB Perturbation	STEIN_ESRRA_TARGETS_UP	Genes up-regulated by ESRRA [GeneID=2101] only.	11	3.184050e-2	1.000000e+0	1.000000e+0	3.140654e+1	3.184050e-2	1	3.184050e-2	1.000000e+0	10	2.100770e-2	1.000000e+0	1.000000e+0	4.760158e+1	2.100770e-2	1	379	1.000000e+0	2.638522e-3	unnamed	SUCLA2
MSigDB Perturbation	WANG_SMARCE1_TARGETS_DN	Genes down-regulated in BT549 cells (breast cancer) by expression of SMARCE1 [GeneID=6605] off a retroviral vector.	12	4.334967e-2	1.000000e+0	1.000000e+0	2.306822e+1	4.334967e-2	1	4.334967e-2	1.000000e+0	9	1.978826e-2	1.000000e+0	1.000000e+0	5.053501e+1	1.978826e-2	1	357	1.000000e+0	2.801120e-3	unnamed	SUCLA2
MSigDB Perturbation	SHEN_SMARCA2_TARGETS_UP	Genes whose expression positively correlated with that of SMARCA2 [GeneID=6595] in prostate cancer samples.	13	4.368157e-2	1.000000e+0	1.000000e+0	2.289295e+1	4.368157e-2	1	4.368157e-2	1.000000e+0	11	2.272601e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	410	1.000000e+0	2.439024e-3	unnamed	SUCLA2
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_24HR_UP	Genes up-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 24h.	14	4.577476e-2	1.000000e+0	1.000000e+0	2.184610e+1	4.577476e-2	1	4.577476e-2	1.000000e+0	19	3.031983e-2	1.000000e+0	1.000000e+0	3.298172e+1	3.031983e-2	1	547	1.000000e+0	1.828154e-3	unnamed	SUCLA2
MSigDB Perturbation	STEIN_ESRRA_TARGETS	Genes regulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	15	4.591289e-2	1.000000e+0	1.000000e+0	2.178037e+1	4.591289e-2	1	4.591289e-2	1.000000e+0	17	2.904495e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	524	1.000000e+0	1.908397e-3	unnamed	SUCLA2
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	Genes in the expression cluster 'Early Progenitors Shared': up-regulated in hematopoietic progenitors from adult bone marrow and from fetal liver.	16	4.893719e-2	1.000000e+0	1.000000e+0	2.043436e+1	4.893719e-2	1	4.893719e-2	1.000000e+0	16	2.821351e-2	1.000000e+0	1.000000e+0	3.544401e+1	2.821351e-2	1	509	1.000000e+0	1.964637e-3	unnamed	SUCLA2
MSigDB Perturbation	ZHANG_BREAST_CANCER_PROGENITORS_UP	Genes up-regulated in cancer stem cells isolated from mammary tumors compared to the non-tumorigenic cells.	17	5.010071e-2	1.000000e+0	1.000000e+0	1.995980e+1	5.010071e-2	1	5.010071e-2	1.000000e+0	12	2.289230e-2	1.000000e+0	1.000000e+0	4.368281e+1	2.289230e-2	1	413	1.000000e+0	2.421308e-3	unnamed	SUCLA2
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_UP	Transcripts enriched in pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	18	5.651646e-2	1.000000e+0	1.000000e+0	1.769396e+1	5.651646e-2	1	5.651646e-2	1.000000e+0	15	2.765922e-2	1.000000e+0	1.000000e+0	3.615431e+1	2.765922e-2	1	499	1.000000e+0	2.004008e-3	unnamed	SUCLA2
MSigDB Perturbation	KIM_ALL_DISORDERS_CALB1_CORR_UP	Genes whose expression significantly and positively correlated with the density of CALB1-positive [GeneID=793]  GABAergic interneurons in the BA9 brain region across all subjects with psychiatric disorders.	19	6.127712e-2	1.000000e+0	1.000000e+0	1.631931e+1	6.127712e-2	1	6.127712e-2	1.000000e+0	18	3.015354e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	544	1.000000e+0	1.838235e-3	unnamed	SUCLA2
MSigDB Perturbation	SCHLOSSER_SERUM_RESPONSE_DN	Cluster 4: genes down-regulated in B493-6 cells (B lymphocytes) upon serum stimulation but not affected by MYC [GeneID=4609].	20	7.399847e-2	1.000000e+0	1.000000e+0	1.351379e+1	7.399847e-2	1	7.399847e-2	1.000000e+0	20	3.835708e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	692	1.000000e+0	1.445087e-3	unnamed	SUCLA2
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	21	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	21	6.801175e-2	1.000000e+0	1.000000e+0	1.470334e+1	6.801175e-2	1	1227	1.000000e+0	8.149959e-4	unnamed	SUCLA2
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	22	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	23	7.654786e-2	1.000000e+0	1.000000e+0	1.306372e+1	7.654786e-2	1	1381	1.000000e+0	7.241130e-4	unnamed	SUCLA2
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_DN	Genes down-regulated in brain from patients with Alzheimer's disease.	23	1.457059e-1	1.000000e+0	1.000000e+0	6.863142e+0	1.457059e-1	1	1.457059e-1	1.000000e+0	22	6.817804e-2	1.000000e+0	1.000000e+0	1.466748e+1	6.817804e-2	1	1230	1.000000e+0	8.130081e-4	unnamed	SUCLA2
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	24	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	24	1.057591e-1	1.000000e+0	1.000000e+0	9.455451e+0	1.057591e-1	1	1908	1.000000e+0	5.241090e-4	unnamed	SUCLA2
MSigDB Predicted Promoter Motifs	V$SF1_Q6	Motif TGRCCTTG matches SF1: splicing factor 1	1	1.991623e-2	1.000000e+0	1.000000e+0	5.021030e+1	1.991623e-2	1	1.991623e-2	1.000000e+0	1	1.358018e-2	1.000000e+0	1.000000e+0	7.363673e+1	1.358018e-2	1	245	1.000000e+0	4.081633e-3	unnamed	SUCLA2
MSigDB Predicted Promoter Motifs	V$ERR1_Q2	Motif NNNTNAAGGTCANN matches ESRRA: estrogen-related receptor alpha	2	2.662137e-2	1.000000e+0	1.000000e+0	3.756380e+1	2.662137e-2	1	2.662137e-2	1.000000e+0	3	1.452248e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	262	1.000000e+0	3.816794e-3	unnamed	SUCLA2
MSigDB Predicted Promoter Motifs	V$RORA1_01	Motif NWAWNNAGGTCAN matches RORA: RAR-related orphan receptor A	3	3.423710e-2	1.000000e+0	1.000000e+0	2.920808e+1	3.423710e-2	1	3.423710e-2	1.000000e+0	2	1.374647e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	248	1.000000e+0	4.032258e-3	unnamed	SUCLA2
MSigDB miRNA Motifs	ATACTGT,MIR-144	Targets of MicroRNA ATACTGT,MIR-144	1	3.746732e-2	1.000000e+0	1.000000e+0	2.668992e+1	3.746732e-2	1	3.746732e-2	1.000000e+0	1	1.075328e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	SUCLA2
MSigDB miRNA Motifs	ATTCTTT,MIR-186	Targets of MicroRNA ATTCTTT,MIR-186	2	4.504027e-2	1.000000e+0	1.000000e+0	2.220235e+1	4.504027e-2	1	4.504027e-2	1.000000e+0	2	1.457791e-2	1.000000e+0	1.000000e+0	6.859696e+1	1.457791e-2	1	263	1.000000e+0	3.802281e-3	unnamed	SUCLA2
InterPro	IPR005809	Succinyl-CoA synthetase, beta subunit	1	7.094094e-4	1.000000e+0	1.000000e+0	1.409623e+3	7.094094e-4	1	7.094094e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	SUCLA2
InterPro	IPR013650	ATP-grasp fold, succinyl-CoA synthetase-type	2	7.500346e-4	1.000000e+0	1.000000e+0	1.333272e+3	7.500346e-4	1	7.500346e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	7.833823e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SUCLA2
InterPro	IPR017866	Succinyl-CoA synthetase, beta subunit, conserved site	2	7.500346e-4	1.000000e+0	1.000000e+0	1.333272e+3	7.500346e-4	1	7.500346e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	7.833823e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SUCLA2
InterPro	IPR005811	ATP-citrate lyase/succinyl-CoA ligase	4	1.117684e-3	1.000000e+0	1.000000e+0	8.947070e+2	1.117684e-3	1	1.117684e-3	1.000000e+0	4	2.217172e-4	1.000000e+0	5.222549e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	SUCLA2
InterPro	IPR011761	ATP-grasp fold	5	1.388034e-3	1.000000e+0	1.000000e+0	7.204433e+2	1.388034e-3	1	1.388034e-3	1.000000e+0	5	7.760102e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	14	1.000000e+0	7.142857e-2	unnamed	SUCLA2
InterPro	IPR013815	ATP-grasp fold, subdomain 1	6	1.999713e-3	1.000000e+0	1.000000e+0	5.000719e+2	1.999713e-3	1	1.999713e-3	1.000000e+0	5	7.760102e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	14	1.000000e+0	7.142857e-2	unnamed	SUCLA2
InterPro	IPR013816	ATP-grasp fold, subdomain 2	7	2.056933e-3	1.000000e+0	1.000000e+0	4.861608e+2	2.056933e-3	1	2.056933e-3	1.000000e+0	7	9.422981e-4	1.000000e+0	1.000000e+0	1.061235e+3	9.422981e-4	1	17	1.000000e+0	5.882353e-2	unnamed	SUCLA2
TreeFam	TF300624	SUCLA2, SUCLG2	1	7.094094e-4	1.000000e+0	1.000000e+0	1.409623e+3	7.094094e-4	1	7.094094e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	SUCLA2
Ensembl Genes	5381	SUCLA2	1	3.604034e-4	1.000000e+0	1.000000e+0	2.774669e+3	3.604034e-4	1	3.604034e-4	1.000000e+0	1	5.542930e-5	1.000000e+0	1.000000e+0	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	SUCLA2
MSigDB Oncogenic Signatures	PIGF_UP.V1_UP	Genes up-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	1	2.376115e-2	1.000000e+0	1.000000e+0	4.208551e+1	2.376115e-2	1	2.376115e-2	1.000000e+0	1	1.025442e-2	1.000000e+0	1.000000e+0	9.751892e+1	1.025442e-2	1	185	1.000000e+0	5.405405e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN	Genes down-regulated in comparison of unstimulated NK cells versus those stimulated with IL2 [GeneID=3600] at 16 h.	1	1.308014e-2	1.000000e+0	1.000000e+0	7.645178e+1	1.308014e-2	1	1.308014e-2	1.000000e+0	19	1.114129e-2	1.000000e+0	1.000000e+0	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	2	1.435079e-2	1.000000e+0	1.000000e+0	6.968259e+1	1.435079e-2	1	1.435079e-2	1.000000e+0	6	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	3	1.487950e-2	1.000000e+0	1.000000e+0	6.720655e+1	1.487950e-2	1	1.487950e-2	1.000000e+0	15	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	4	1.539378e-2	1.000000e+0	1.000000e+0	6.496130e+1	1.539378e-2	1	1.539378e-2	1.000000e+0	3	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE15930_STIM_VS_STIM_AND_IL-12_72H_CD8_T_CELL_UP	Genes up-regulated in comparison of unstimulated CD8 T cells at 72 h versus CD8 T cells at 72 h after stimulation with IL12.	5	1.556138e-2	1.000000e+0	1.000000e+0	6.426166e+1	1.556138e-2	1	1.556138e-2	1.000000e+0	20	1.141844e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	206	1.000000e+0	4.854369e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE14026_TH1_VS_TH17_DN	Genes down-regulated in comparison of Th1 cells versus Th17 cells.	6	1.646343e-2	1.000000e+0	1.000000e+0	6.074067e+1	1.646343e-2	1	1.646343e-2	1.000000e+0	1	1.030985e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	186	1.000000e+0	5.376344e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 3 days after the stimulation.	7	1.656613e-2	1.000000e+0	1.000000e+0	6.036413e+1	1.656613e-2	1	1.656613e-2	1.000000e+0	3	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	8	1.685976e-2	1.000000e+0	1.000000e+0	5.931284e+1	1.685976e-2	1	1.685976e-2	1.000000e+0	1	1.030985e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	186	1.000000e+0	5.376344e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE25087_FETAL_VS_ADULT_TREG_UP	Genes up-regulated in comparison of fetal regulatory T cell (Treg) versus adult regulatory T cell (Treg).	9	1.693544e-2	1.000000e+0	1.000000e+0	5.904778e+1	1.693544e-2	1	1.693544e-2	1.000000e+0	12	1.080871e-2	1.000000e+0	1.000000e+0	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN	Genes down-regulated in comparison of B cells from LAIV influenza vaccinee at day 7 post-vaccination versus those from TIV influenza vaccinee at day 7 post-vaccination.	10	1.709472e-2	1.000000e+0	1.000000e+0	5.849759e+1	1.709472e-2	1	1.709472e-2	1.000000e+0	6	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 12 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 12 h.	11	1.834132e-2	1.000000e+0	1.000000e+0	5.452172e+1	1.834132e-2	1	1.834132e-2	1.000000e+0	15	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus unstimulated NK cells.	12	1.880828e-2	1.000000e+0	1.000000e+0	5.316806e+1	1.880828e-2	1	1.880828e-2	1.000000e+0	15	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP	Genes up-regulated in comparison of splenic primary CD8 effector T cells at day 8 post-chronic infection versus splenic secondary CD8 effector T cells at day 8 post-chronic infection.	13	1.928131e-2	1.000000e+0	1.000000e+0	5.186369e+1	1.928131e-2	1	1.928131e-2	1.000000e+0	5	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP	Genes up-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.	14	1.959098e-2	1.000000e+0	1.000000e+0	5.104391e+1	1.959098e-2	1	1.959098e-2	1.000000e+0	14	1.086414e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	196	1.000000e+0	5.102041e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE3982_MAC_VS_BASOPHIL_UP	Genes up-regulated in comparison of macrophages versus basophils.	15	1.961962e-2	1.000000e+0	1.000000e+0	5.096939e+1	1.961962e-2	1	1.961962e-2	1.000000e+0	12	1.080871e-2	1.000000e+0	1.000000e+0	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 12 h.	16	2.041558e-2	1.000000e+0	1.000000e+0	4.898221e+1	2.041558e-2	1	2.041558e-2	1.000000e+0	18	1.103043e-2	1.000000e+0	1.000000e+0	9.065829e+1	1.103043e-2	1	199	1.000000e+0	5.025126e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN	Genes down-regulated in comparison of ActCD4 versus WTActCD4 (see Fig. 1 in the paper for details).	17	2.043732e-2	1.000000e+0	1.000000e+0	4.893010e+1	2.043732e-2	1	2.043732e-2	1.000000e+0	10	1.069785e-2	1.000000e+0	1.000000e+0	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	18	2.057159e-2	1.000000e+0	1.000000e+0	4.861073e+1	2.057159e-2	1	2.057159e-2	1.000000e+0	6	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN	Genes down-regulated in comparison of unstimulated macrophage cells versus macrophage cells stimulated with LPS (TLR4 agonist) for 20 min.	19	2.181921e-2	1.000000e+0	1.000000e+0	4.583118e+1	2.181921e-2	1	2.181921e-2	1.000000e+0	6	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SUCLA2
MSigDB Immunologic Signatures	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN	Genes down-regulated in comparison of memory CD8 T cells versus naive CD8 T cells.	20	2.577519e-2	1.000000e+0	1.000000e+0	3.879700e+1	2.577519e-2	1	2.577519e-2	1.000000e+0	11	1.075328e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	SUCLA2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
